Medical Devices & Consumables
Global H. pylori Stool Antigen Tests Market Research Report 2026
- Nov 14, 26
- ID: 760890
- Pages: 155
- Figures: 150
- Views: 17
The global H. pylori Stool Antigen Tests market was valued at US$ 168 million in 2025 and is anticipated to reach US$ 267 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
H. pylori Stool Antigen Tests are in vitro diagnostic products designed to detect Helicobacter pylori antigens in human stool specimens for non-invasive identification of active H. pylori infection and, where supported by product labeling and clinical practice, confirmation of eradication after therapy. Commercial products are available as visual rapid-test cassettes, reader-assisted cassettes, microplate kits, and dedicated reagents for automated immunoassay analyzers. The principal technology routes include lateral flow immunochromatography, fluorescence immunoassay, enzyme immunoassay, chemiluminescence immunoassay, and latex turbidimetric immunoassay. Product outputs range from qualitative positive or negative interpretation to quantitative-capable measurements on instrument-based platforms. H. pylori Stool Antigen Tests are used across hospital laboratories, hospital point-of-care settings, gastroenterology clinics, primary-care facilities, independent reference laboratories, and selected home self-testing channels, forming a diagnostic category that combines decentralized rapid testing with centralized laboratory immunoassay workflows. Current commercial products also support both initial active-infection assessment and post-treatment confirmation of antigen clearance.
Key Findings
Lateral flow immunochromatography remains the principal volume technology in the global product mix
Professional medical testing remains the dominant use setting while regulated home self-testing is expanding
Market Trends
The H. pylori Stool Antigen Tests market is evolving from a product structure dominated by visually interpreted rapid tests toward a broader combination of rapid testing, reader-assisted assays, and automated laboratory immunoassays. Lateral flow cassettes retain a strong position because they offer short turnaround time, relatively simple sample preparation, limited equipment requirements, and broad suitability for decentralized testing. At the same time, fluorescence immunoassay and other reader-based formats are gaining relevance in facilities seeking objective interpretation and standardized workflows, while microplate enzyme immunoassays and automated reagent systems continue to serve higher-throughput laboratories. Commercial product portfolios already demonstrate this coexistence of one-step lateral flow, quantitative-capable EIA, and instrument-oriented testing. Product development is increasingly focused on reducing hands-on time, improving stool-sample handling, supporting objective result interpretation, and extending testing into smaller clinics and selected home-use settings. The longer-term direction is therefore not replacement of one technology by another, but segmentation between high-volume rapid testing and higher-value laboratory or reader-based solutions.
Market Dynamics
Drivers
Demand is supported by the large global burden of H. pylori infection and by the clinical need to identify active infection through non-invasive methods. Stool antigen testing can be deployed without endoscopy and is suitable for both decentralized and laboratory-based workflows, supporting use across primary care, gastroenterology, hospitals, and reference laboratories. A further recurring demand layer is created by eradication confirmation: the 2024 American College of Gastroenterology guideline recommends test-of-cure assessment at least four weeks after therapy and identifies fecal antigen testing as one of the recommended methods. This creates a structural pathway in which some patients generate both initial-diagnosis and post-treatment testing demand. Expansion of POCT infrastructure, greater availability of rapid immunochromatographic products, and broader access to standardized diagnostic kits in emerging markets also support test-volume growth.
Restraints
The market faces substitution pressure from urea breath testing, biopsy-based testing, and molecular diagnostic methods, while local clinical practice patterns differ significantly across countries. Stool collection and specimen preparation remain less convenient for some patients than breath-based testing, particularly in outpatient and consumer settings. Test timing also matters: acid suppression, antibiotics, and bismuth-containing therapy can increase the risk of false-negative results when testing is performed too soon after treatment, which requires disciplined clinical workflows. Instrument-based fluorescence, enzyme immunoassay, chemiluminescence, and automated turbidimetric solutions additionally require analyzer infrastructure or laboratory capacity, limiting penetration in low-throughput settings. In the rapid-test segment, high manufacturing capacity among Asian suppliers and extensive OEM competition continue to constrain manufacturer-level price expansion despite product upgrades.
Opportunities
The most attractive opportunities are concentrated in decentralized active-infection testing, structured eradication confirmation, reader-assisted rapid diagnostics, laboratory automation, and regulated home self-testing. Rapid stool antigen products can extend H. pylori testing into clinics that lack breath-analysis equipment or advanced laboratory infrastructure, while reader-based assays can improve interpretation consistency in decentralized professional settings. Automated and quantitative-capable products create additional opportunities in hospital and reference laboratories where throughput, reproducibility, and workflow integration are important. Manufacturers with strong lateral-flow production capability can also expand internationally through OEM and private-label channels, particularly in fragmented markets where local distributors and brands remain important. Home-use products provide an additional route to market where regulatory authorization and clear referral pathways are established, although this channel remains complementary to professional testing rather than a replacement for it.
Challenges
Long-term competition is shaped by differences in assay performance, antibody systems, sample-preparation methods, regulatory requirements, and manufacturing quality. The category contains multinational diagnostic groups, specialized immunodiagnostic manufacturers, regional rapid-test companies, and large OEM producers, which creates significant pricing and channel fragmentation. Maintaining lot-to-lot consistency is particularly important because stool matrices are heterogeneous and rapid assays rely heavily on extraction quality, membrane performance, and antibody specificity. Different regulatory pathways for professional-use and self-test products also make simultaneous global commercialization difficult. Another challenge is identifying the true competitive structure because a single manufacturing group may supply several regional brands or operate through multiple subsidiaries, making group-level consolidation necessary when assessing supplier concentration.
Industry Chain Analysis
The upstream segment includes monoclonal and polyclonal antibodies, nitrocellulose membranes, conjugate pads, absorbent materials, colloidal and latex particles, fluorescent labels, enzymes, substrates, buffers, microplates, plastic cassettes, stool collection components, calibrators, controls, and packaging materials. Antibody affinity and specificity, membrane consistency, extraction-buffer formulation, conjugate stability, and reagent shelf life directly affect diagnostic performance and manufacturing yield. Instrument-based H. pylori Stool Antigen Tests additionally require analyzer-compatible reagent containers, optical or fluorescent labels, calibration systems, and dedicated consumables, creating a more integrated upstream supply structure than conventional visual lateral-flow products.
The midstream segment covers assay development, biological raw-material preparation, coating and conjugation, strip lamination, cassette assembly, reagent filling, calibration, quality control, packaging, regulatory registration, and commercial manufacturing. Lateral-flow producers create value primarily through manufacturing scale, yield control, product consistency, low unit cost, regulatory coverage, and distribution efficiency. Instrument-platform suppliers capture additional value through proprietary reagents, analyzer compatibility, software-assisted interpretation, and recurring consumable demand. Downstream demand comes from hospital central laboratories, hospital point-of-care departments, gastroenterology and primary-care clinics, independent reference laboratories, distributors, and regulated home-testing channels. This places H. pylori Stool Antigen Tests in the midstream IVD reagent and POCT manufacturing segment of the broader medical-device industry chain.
Segment Insights
By detection technology, lateral flow immunochromatography represents the broadest commercial product base and remains the principal shipment-volume segment. Commercial products are commonly configured as single-step or short-procedure cassettes for qualitative antigen detection in stool, with several leading suppliers offering test times around ten minutes and multi-test professional packages. Fluorescence immunoassay occupies a more instrument-dependent position and is suited to facilities that require rapid turnaround combined with objective reader interpretation. Enzyme immunoassay remains relevant for batch laboratory testing, with established products supplied in 96-well formats and, in some cases, supporting both qualitative and quantitative analysis. Chemiluminescence and latex turbidimetric immunoassays are concentrated in automated laboratory settings, while less widely adopted technologies are grouped into the Other category.
By operating format, the market can be divided into visual cassettes, reader-assisted cassettes, microplate kits, automated analyzer reagents, and Other products. Visual cassettes dominate decentralized testing because of their low equipment requirement, while reader-assisted formats provide more standardized interpretation. Microplate kits support batch processing, and automated analyzer reagents target larger laboratories seeking higher throughput and workflow integration. By result capability, qualitative-only products account for most rapid-test consumption, whereas quantitative-capable products are more concentrated in instrument-based systems. This product structure creates two distinct competitive models: high-volume rapid tests driven by cost, manufacturing scale, and channel reach, and higher-value instrument-based assays driven by automation, reproducibility, and recurring reagent consumption.
Downstream Market Opportunities
By clinical purpose, the two core application pathways are active-infection diagnosis and eradication confirmation. Active-infection testing generates demand from patients presenting with dyspeptic symptoms, ulcer-related conditions, or other clinical indications for H. pylori assessment, while post-treatment confirmation creates recurring demand after eradication therapy. Professional guidelines supporting test-of-cure reinforce the role of stool antigen testing in this second application pathway.
By end-use setting, primary-care and gastroenterology clinics favor rapid and easy-to-operate formats, while hospital central laboratories and independent reference laboratories support batch and automated immunoassays. Hospital point-of-care environments provide an intermediate opportunity for reader-assisted and fluorescence-based products where same-visit decision-making and objective interpretation are valuable. Home self-testing represents an emerging incremental channel in selected regulated markets, supported by single-test packaging and simplified procedures, but professional medical testing remains the dominant utilization setting because diagnosis, treatment selection, and eradication follow-up generally require integration with clinical care.
Regional Insights
North America and Europe are mature, higher-value diagnostic markets characterized by established clinical pathways, strong regulatory oversight, specialist IVD suppliers, and meaningful use of both branded rapid assays and laboratory immunoassay systems. The United States supports established stool antigen products for both active-infection diagnosis and post-treatment confirmation, while European suppliers maintain broad portfolios spanning lateral flow, EIA, reader-based, and automated technologies. Japan and South Korea have strong domestic diagnostic manufacturing capabilities and support a mix of proprietary rapid-test and instrument-based immunoassay platforms.
China is one of the most important manufacturing and export supply bases for H. pylori Stool Antigen Tests, supported by large-scale rapid-test production, extensive OEM capability, broad domestic IVD distribution, and a growing portfolio of professional and self-test products. China Taiwan also hosts specialized rapid-test manufacturers with international and private-label business. India has a sizable base of regional IVD producers and remains strongly price-sensitive, while Southeast Asia depends more heavily on imported products and local distribution networks. Israel and Türkiye contribute specialized regional manufacturers, and Latin America remains a mixed market in which imported rapid tests coexist with a more limited local manufacturing base.
Competitive Landscape Analysis
The competitive landscape is fragmented and combines multinational diagnostic groups, large-scale rapid-test manufacturers, specialist immunodiagnostic companies, and regional IVD producers. Group consolidation is important when assessing actual competitive concentration. SSI Diagnostica operates as one group incorporating portfolios such as TECHLAB and CTK Biotech, while Meridian Bioscience has been owned through the SD Biosensor and SJL Partners consortium since completion of the 2023 transaction; Meridian continues to operate as an independent entity under that ownership. Large-scale suppliers such as Abbott Laboratories, SD Biosensor, SSI Diagnostica, ACON Laboratories, Guangzhou Wondfo Biotech, Zhejiang Orient Gene Biotech, HANGZHOU ALLTEST BIOTECH, R-Biopharm, Denka, Getein Biotech, and Sentinel Diagnostics compete through combinations of production scale, technology breadth, registration coverage, OEM capability, and international distribution. Mid-sized companies including Boditech Med, Certest Biotec, MIZUHO MEDY, Wakamoto Pharmaceutical, Humasis, Innovita Biological Technology, Assure Tech, Trinity Biotech, Savyon Diagnostics, nal von minden, DIALAB, Biopanda, Apacor, Panion & BF Biotech, STRONG BIOTECH, Lepu Diagnostics, and Cofoe Medical compete through regional distribution, specialized assay formats, flexible product positioning, and targeted technology platforms. No single competitive model dominates across rapid testing, laboratory automation, OEM supply, and home-use channels.
Report Scope
This report delivers a comprehensive overview of the global H. pylori Stool Antigen Tests market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding H. pylori Stool Antigen Tests. The H. pylori Stool Antigen Tests market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global H. pylori Stool Antigen Tests market comprehensively. Regional market sizes by Type, by Application, by Operating Format, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist H. pylori Stool Antigen Tests manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Abbott Laboratories
SD Biosensor, Inc.
SSI Diagnostica A/S
ACON Laboratories, Inc.
Guangzhou Wondfo Biotech Co., Ltd.
Zhejiang Orient Gene Biotech Co., Ltd.
HANGZHOU ALLTEST BIOTECH CO., LTD.
R-Biopharm AG
Denka Company Limited
Autobio Diagnostics Co., Ltd.
Getein Biotech, Inc.
Sentinel Diagnostics
Boditech Med Inc.
Certest Biotec, S.L.
MIZUHO MEDY Co., Ltd.
Wakamoto Pharmaceutical Co., Ltd.
Humasis Co., Ltd.
Innovita Biological Technology Co., Ltd.
Assure Tech Hangzhou Co., Ltd.
Trinity Biotech plc
Savyon Diagnostics Ltd.
nal von minden GmbH
DIALAB GmbH
Biopanda Reagents Ltd.
Apacor Limited
Panion & BF Biotech, Inc.
STRONG BIOTECH CORPORATION
Beijing Lepu Diagnostics Technology Co., Ltd.
Cofoe Medical Technology Co., Ltd.
Segment by Type
Lateral Flow Immunochromatography
Fluorescence Immunoassay
Enzyme Immunoassay
Chemiluminescence Immunoassay
Latex Turbidimetric Immunoassay
Other
Segment by Operating Format
Visual Cassette
Reader Assisted Cassette
Microplate Kit
Automated Analyzer Reagent
Other
by Application
Home Self-Testing
Primary Care Clinic Testing
Gastroenterology Clinic Testing
Hospital Point-of-Care Testing
Hospital Central Laboratory Testing
Independent Reference Laboratory Testing
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Operating Format, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for H. pylori Stool Antigen Tests manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines H. pylori Stool Antigen Tests sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
H. pylori Stool Antigen Tests are in vitro diagnostic products designed to detect Helicobacter pylori antigens in human stool specimens for non-invasive identification of active H. pylori infection and, where supported by product labeling and clinical practice, confirmation of eradication after therapy. Commercial products are available as visual rapid-test cassettes, reader-assisted cassettes, microplate kits, and dedicated reagents for automated immunoassay analyzers. The principal technology routes include lateral flow immunochromatography, fluorescence immunoassay, enzyme immunoassay, chemiluminescence immunoassay, and latex turbidimetric immunoassay. Product outputs range from qualitative positive or negative interpretation to quantitative-capable measurements on instrument-based platforms. H. pylori Stool Antigen Tests are used across hospital laboratories, hospital point-of-care settings, gastroenterology clinics, primary-care facilities, independent reference laboratories, and selected home self-testing channels, forming a diagnostic category that combines decentralized rapid testing with centralized laboratory immunoassay workflows. Current commercial products also support both initial active-infection assessment and post-treatment confirmation of antigen clearance.
Key Findings
Lateral flow immunochromatography remains the principal volume technology in the global product mix
Professional medical testing remains the dominant use setting while regulated home self-testing is expanding
Market Trends
The H. pylori Stool Antigen Tests market is evolving from a product structure dominated by visually interpreted rapid tests toward a broader combination of rapid testing, reader-assisted assays, and automated laboratory immunoassays. Lateral flow cassettes retain a strong position because they offer short turnaround time, relatively simple sample preparation, limited equipment requirements, and broad suitability for decentralized testing. At the same time, fluorescence immunoassay and other reader-based formats are gaining relevance in facilities seeking objective interpretation and standardized workflows, while microplate enzyme immunoassays and automated reagent systems continue to serve higher-throughput laboratories. Commercial product portfolios already demonstrate this coexistence of one-step lateral flow, quantitative-capable EIA, and instrument-oriented testing. Product development is increasingly focused on reducing hands-on time, improving stool-sample handling, supporting objective result interpretation, and extending testing into smaller clinics and selected home-use settings. The longer-term direction is therefore not replacement of one technology by another, but segmentation between high-volume rapid testing and higher-value laboratory or reader-based solutions.
Market Dynamics
Drivers
Demand is supported by the large global burden of H. pylori infection and by the clinical need to identify active infection through non-invasive methods. Stool antigen testing can be deployed without endoscopy and is suitable for both decentralized and laboratory-based workflows, supporting use across primary care, gastroenterology, hospitals, and reference laboratories. A further recurring demand layer is created by eradication confirmation: the 2024 American College of Gastroenterology guideline recommends test-of-cure assessment at least four weeks after therapy and identifies fecal antigen testing as one of the recommended methods. This creates a structural pathway in which some patients generate both initial-diagnosis and post-treatment testing demand. Expansion of POCT infrastructure, greater availability of rapid immunochromatographic products, and broader access to standardized diagnostic kits in emerging markets also support test-volume growth.
Restraints
The market faces substitution pressure from urea breath testing, biopsy-based testing, and molecular diagnostic methods, while local clinical practice patterns differ significantly across countries. Stool collection and specimen preparation remain less convenient for some patients than breath-based testing, particularly in outpatient and consumer settings. Test timing also matters: acid suppression, antibiotics, and bismuth-containing therapy can increase the risk of false-negative results when testing is performed too soon after treatment, which requires disciplined clinical workflows. Instrument-based fluorescence, enzyme immunoassay, chemiluminescence, and automated turbidimetric solutions additionally require analyzer infrastructure or laboratory capacity, limiting penetration in low-throughput settings. In the rapid-test segment, high manufacturing capacity among Asian suppliers and extensive OEM competition continue to constrain manufacturer-level price expansion despite product upgrades.
Opportunities
The most attractive opportunities are concentrated in decentralized active-infection testing, structured eradication confirmation, reader-assisted rapid diagnostics, laboratory automation, and regulated home self-testing. Rapid stool antigen products can extend H. pylori testing into clinics that lack breath-analysis equipment or advanced laboratory infrastructure, while reader-based assays can improve interpretation consistency in decentralized professional settings. Automated and quantitative-capable products create additional opportunities in hospital and reference laboratories where throughput, reproducibility, and workflow integration are important. Manufacturers with strong lateral-flow production capability can also expand internationally through OEM and private-label channels, particularly in fragmented markets where local distributors and brands remain important. Home-use products provide an additional route to market where regulatory authorization and clear referral pathways are established, although this channel remains complementary to professional testing rather than a replacement for it.
Challenges
Long-term competition is shaped by differences in assay performance, antibody systems, sample-preparation methods, regulatory requirements, and manufacturing quality. The category contains multinational diagnostic groups, specialized immunodiagnostic manufacturers, regional rapid-test companies, and large OEM producers, which creates significant pricing and channel fragmentation. Maintaining lot-to-lot consistency is particularly important because stool matrices are heterogeneous and rapid assays rely heavily on extraction quality, membrane performance, and antibody specificity. Different regulatory pathways for professional-use and self-test products also make simultaneous global commercialization difficult. Another challenge is identifying the true competitive structure because a single manufacturing group may supply several regional brands or operate through multiple subsidiaries, making group-level consolidation necessary when assessing supplier concentration.
Industry Chain Analysis
The upstream segment includes monoclonal and polyclonal antibodies, nitrocellulose membranes, conjugate pads, absorbent materials, colloidal and latex particles, fluorescent labels, enzymes, substrates, buffers, microplates, plastic cassettes, stool collection components, calibrators, controls, and packaging materials. Antibody affinity and specificity, membrane consistency, extraction-buffer formulation, conjugate stability, and reagent shelf life directly affect diagnostic performance and manufacturing yield. Instrument-based H. pylori Stool Antigen Tests additionally require analyzer-compatible reagent containers, optical or fluorescent labels, calibration systems, and dedicated consumables, creating a more integrated upstream supply structure than conventional visual lateral-flow products.
The midstream segment covers assay development, biological raw-material preparation, coating and conjugation, strip lamination, cassette assembly, reagent filling, calibration, quality control, packaging, regulatory registration, and commercial manufacturing. Lateral-flow producers create value primarily through manufacturing scale, yield control, product consistency, low unit cost, regulatory coverage, and distribution efficiency. Instrument-platform suppliers capture additional value through proprietary reagents, analyzer compatibility, software-assisted interpretation, and recurring consumable demand. Downstream demand comes from hospital central laboratories, hospital point-of-care departments, gastroenterology and primary-care clinics, independent reference laboratories, distributors, and regulated home-testing channels. This places H. pylori Stool Antigen Tests in the midstream IVD reagent and POCT manufacturing segment of the broader medical-device industry chain.
Segment Insights
By detection technology, lateral flow immunochromatography represents the broadest commercial product base and remains the principal shipment-volume segment. Commercial products are commonly configured as single-step or short-procedure cassettes for qualitative antigen detection in stool, with several leading suppliers offering test times around ten minutes and multi-test professional packages. Fluorescence immunoassay occupies a more instrument-dependent position and is suited to facilities that require rapid turnaround combined with objective reader interpretation. Enzyme immunoassay remains relevant for batch laboratory testing, with established products supplied in 96-well formats and, in some cases, supporting both qualitative and quantitative analysis. Chemiluminescence and latex turbidimetric immunoassays are concentrated in automated laboratory settings, while less widely adopted technologies are grouped into the Other category.
By operating format, the market can be divided into visual cassettes, reader-assisted cassettes, microplate kits, automated analyzer reagents, and Other products. Visual cassettes dominate decentralized testing because of their low equipment requirement, while reader-assisted formats provide more standardized interpretation. Microplate kits support batch processing, and automated analyzer reagents target larger laboratories seeking higher throughput and workflow integration. By result capability, qualitative-only products account for most rapid-test consumption, whereas quantitative-capable products are more concentrated in instrument-based systems. This product structure creates two distinct competitive models: high-volume rapid tests driven by cost, manufacturing scale, and channel reach, and higher-value instrument-based assays driven by automation, reproducibility, and recurring reagent consumption.
Downstream Market Opportunities
By clinical purpose, the two core application pathways are active-infection diagnosis and eradication confirmation. Active-infection testing generates demand from patients presenting with dyspeptic symptoms, ulcer-related conditions, or other clinical indications for H. pylori assessment, while post-treatment confirmation creates recurring demand after eradication therapy. Professional guidelines supporting test-of-cure reinforce the role of stool antigen testing in this second application pathway.
By end-use setting, primary-care and gastroenterology clinics favor rapid and easy-to-operate formats, while hospital central laboratories and independent reference laboratories support batch and automated immunoassays. Hospital point-of-care environments provide an intermediate opportunity for reader-assisted and fluorescence-based products where same-visit decision-making and objective interpretation are valuable. Home self-testing represents an emerging incremental channel in selected regulated markets, supported by single-test packaging and simplified procedures, but professional medical testing remains the dominant utilization setting because diagnosis, treatment selection, and eradication follow-up generally require integration with clinical care.
Regional Insights
North America and Europe are mature, higher-value diagnostic markets characterized by established clinical pathways, strong regulatory oversight, specialist IVD suppliers, and meaningful use of both branded rapid assays and laboratory immunoassay systems. The United States supports established stool antigen products for both active-infection diagnosis and post-treatment confirmation, while European suppliers maintain broad portfolios spanning lateral flow, EIA, reader-based, and automated technologies. Japan and South Korea have strong domestic diagnostic manufacturing capabilities and support a mix of proprietary rapid-test and instrument-based immunoassay platforms.
China is one of the most important manufacturing and export supply bases for H. pylori Stool Antigen Tests, supported by large-scale rapid-test production, extensive OEM capability, broad domestic IVD distribution, and a growing portfolio of professional and self-test products. China Taiwan also hosts specialized rapid-test manufacturers with international and private-label business. India has a sizable base of regional IVD producers and remains strongly price-sensitive, while Southeast Asia depends more heavily on imported products and local distribution networks. Israel and Türkiye contribute specialized regional manufacturers, and Latin America remains a mixed market in which imported rapid tests coexist with a more limited local manufacturing base.
Competitive Landscape Analysis
The competitive landscape is fragmented and combines multinational diagnostic groups, large-scale rapid-test manufacturers, specialist immunodiagnostic companies, and regional IVD producers. Group consolidation is important when assessing actual competitive concentration. SSI Diagnostica operates as one group incorporating portfolios such as TECHLAB and CTK Biotech, while Meridian Bioscience has been owned through the SD Biosensor and SJL Partners consortium since completion of the 2023 transaction; Meridian continues to operate as an independent entity under that ownership. Large-scale suppliers such as Abbott Laboratories, SD Biosensor, SSI Diagnostica, ACON Laboratories, Guangzhou Wondfo Biotech, Zhejiang Orient Gene Biotech, HANGZHOU ALLTEST BIOTECH, R-Biopharm, Denka, Getein Biotech, and Sentinel Diagnostics compete through combinations of production scale, technology breadth, registration coverage, OEM capability, and international distribution. Mid-sized companies including Boditech Med, Certest Biotec, MIZUHO MEDY, Wakamoto Pharmaceutical, Humasis, Innovita Biological Technology, Assure Tech, Trinity Biotech, Savyon Diagnostics, nal von minden, DIALAB, Biopanda, Apacor, Panion & BF Biotech, STRONG BIOTECH, Lepu Diagnostics, and Cofoe Medical compete through regional distribution, specialized assay formats, flexible product positioning, and targeted technology platforms. No single competitive model dominates across rapid testing, laboratory automation, OEM supply, and home-use channels.
Report Scope
This report delivers a comprehensive overview of the global H. pylori Stool Antigen Tests market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding H. pylori Stool Antigen Tests. The H. pylori Stool Antigen Tests market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global H. pylori Stool Antigen Tests market comprehensively. Regional market sizes by Type, by Application, by Operating Format, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist H. pylori Stool Antigen Tests manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Abbott Laboratories
SD Biosensor, Inc.
SSI Diagnostica A/S
ACON Laboratories, Inc.
Guangzhou Wondfo Biotech Co., Ltd.
Zhejiang Orient Gene Biotech Co., Ltd.
HANGZHOU ALLTEST BIOTECH CO., LTD.
R-Biopharm AG
Denka Company Limited
Autobio Diagnostics Co., Ltd.
Getein Biotech, Inc.
Sentinel Diagnostics
Boditech Med Inc.
Certest Biotec, S.L.
MIZUHO MEDY Co., Ltd.
Wakamoto Pharmaceutical Co., Ltd.
Humasis Co., Ltd.
Innovita Biological Technology Co., Ltd.
Assure Tech Hangzhou Co., Ltd.
Trinity Biotech plc
Savyon Diagnostics Ltd.
nal von minden GmbH
DIALAB GmbH
Biopanda Reagents Ltd.
Apacor Limited
Panion & BF Biotech, Inc.
STRONG BIOTECH CORPORATION
Beijing Lepu Diagnostics Technology Co., Ltd.
Cofoe Medical Technology Co., Ltd.
Segment by Type
Lateral Flow Immunochromatography
Fluorescence Immunoassay
Enzyme Immunoassay
Chemiluminescence Immunoassay
Latex Turbidimetric Immunoassay
Other
Segment by Operating Format
Visual Cassette
Reader Assisted Cassette
Microplate Kit
Automated Analyzer Reagent
Other
by Application
Home Self-Testing
Primary Care Clinic Testing
Gastroenterology Clinic Testing
Hospital Point-of-Care Testing
Hospital Central Laboratory Testing
Independent Reference Laboratory Testing
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Operating Format, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for H. pylori Stool Antigen Tests manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines H. pylori Stool Antigen Tests sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 H. pylori Stool Antigen Tests Market Overview
1.1 Product Definition
1.2 H. pylori Stool Antigen Tests by Type
1.2.1 Global H. pylori Stool Antigen Tests Market Value by Type: 2025 vs 2032
1.2.2 Lateral Flow Immunochromatography
1.2.3 Fluorescence Immunoassay
1.2.4 Enzyme Immunoassay
1.2.5 Chemiluminescence Immunoassay
1.2.6 Latex Turbidimetric Immunoassay
1.2.7 Other
1.3 H. pylori Stool Antigen Tests by Operating Format
1.3.1 Global H. pylori Stool Antigen Tests Market Value by Operating Format: 2025 vs 2032
1.3.2 Visual Cassette
1.3.3 Reader Assisted Cassette
1.3.4 Microplate Kit
1.3.5 Automated Analyzer Reagent
1.3.6 Other
1.4 H. pylori Stool Antigen Tests by Application
1.4.1 Global H. pylori Stool Antigen Tests Market Value by Application: 2025 vs 2032
1.4.2 Home Self-Testing
1.4.3 Primary Care Clinic Testing
1.4.4 Gastroenterology Clinic Testing
1.4.5 Hospital Point-of-Care Testing
1.4.6 Hospital Central Laboratory Testing
1.4.7 Independent Reference Laboratory Testing
1.4.8 Other
1.5 Global H. pylori Stool Antigen Tests Market Size Estimates and Forecasts
1.5.1 Global H. pylori Stool Antigen Tests Revenue 2021–2032
1.5.2 Global H. pylori Stool Antigen Tests Sales 2021–2032
1.5.3 Global H. pylori Stool Antigen Tests Market Average Price (2021–2032)
1.6 Assumptions and Limitations
2 H. pylori Stool Antigen Tests Market Competition by Manufacturers
2.1 Global H. pylori Stool Antigen Tests Sales Market Share by Manufacturers (2021–2026)
2.2 Global H. pylori Stool Antigen Tests Revenue Market Share by Manufacturers (2021–2026)
2.3 Global H. pylori Stool Antigen Tests Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of H. pylori Stool Antigen Tests, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of H. pylori Stool Antigen Tests, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of H. pylori Stool Antigen Tests, Product Types and Applications
2.7 Global Key Manufacturers of H. pylori Stool Antigen Tests, Date of Entry into the Industry
2.8 Global H. pylori Stool Antigen Tests Market Competitive Situation and Trends
2.8.1 Global H. pylori Stool Antigen Tests Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global H. pylori Stool Antigen Tests Players Market Share by Revenue
2.8.3 Global H. pylori Stool Antigen Tests Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global H. pylori Stool Antigen Tests Market Scenario by Region
3.1 Global H. pylori Stool Antigen Tests Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global H. pylori Stool Antigen Tests Sales by Region: 2021–2032
3.2.1 Global H. pylori Stool Antigen Tests Sales by Region: 2021–2026
3.2.2 Global H. pylori Stool Antigen Tests Sales by Region: 2027–2032
3.3 Global H. pylori Stool Antigen Tests Revenue by Region: 2021–2032
3.3.1 Global H. pylori Stool Antigen Tests Revenue by Region: 2021–2026
3.3.2 Global H. pylori Stool Antigen Tests Revenue by Region: 2027–2032
3.4 North America H. pylori Stool Antigen Tests Market Facts & Figures by Country
3.4.1 North America H. pylori Stool Antigen Tests Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America H. pylori Stool Antigen Tests Sales by Country (2021–2032)
3.4.3 North America H. pylori Stool Antigen Tests Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe H. pylori Stool Antigen Tests Market Facts & Figures by Country
3.5.1 Europe H. pylori Stool Antigen Tests Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe H. pylori Stool Antigen Tests Sales by Country (2021–2032)
3.5.3 Europe H. pylori Stool Antigen Tests Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific H. pylori Stool Antigen Tests Market Facts & Figures by Region
3.6.1 Asia Pacific H. pylori Stool Antigen Tests Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific H. pylori Stool Antigen Tests Sales by Region (2021–2032)
3.6.3 Asia Pacific H. pylori Stool Antigen Tests Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America H. pylori Stool Antigen Tests Market Facts & Figures by Country
3.7.1 Latin America H. pylori Stool Antigen Tests Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America H. pylori Stool Antigen Tests Sales by Country (2021–2032)
3.7.3 Latin America H. pylori Stool Antigen Tests Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa H. pylori Stool Antigen Tests Market Facts & Figures by Country
3.8.1 Middle East and Africa H. pylori Stool Antigen Tests Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa H. pylori Stool Antigen Tests Sales by Country (2021–2032)
3.8.3 Middle East and Africa H. pylori Stool Antigen Tests Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global H. pylori Stool Antigen Tests Sales by Type (2021–2032)
4.1.1 Global H. pylori Stool Antigen Tests Sales by Type (2021–2026)
4.1.2 Global H. pylori Stool Antigen Tests Sales by Type (2027–2032)
4.1.3 Global H. pylori Stool Antigen Tests Sales Market Share by Type (2021–2032)
4.2 Global H. pylori Stool Antigen Tests Revenue by Type (2021–2032)
4.2.1 Global H. pylori Stool Antigen Tests Revenue by Type (2021–2026)
4.2.2 Global H. pylori Stool Antigen Tests Revenue by Type (2027–2032)
4.2.3 Global H. pylori Stool Antigen Tests Revenue Market Share by Type (2021–2032)
4.3 Global H. pylori Stool Antigen Tests Price by Type (2021–2032)
5 Segment by Application
5.1 Global H. pylori Stool Antigen Tests Sales by Application (2021–2032)
5.1.1 Global H. pylori Stool Antigen Tests Sales by Application (2021–2026)
5.1.2 Global H. pylori Stool Antigen Tests Sales by Application (2027–2032)
5.1.3 Global H. pylori Stool Antigen Tests Sales Market Share by Application (2021–2032)
5.2 Global H. pylori Stool Antigen Tests Revenue by Application (2021–2032)
5.2.1 Global H. pylori Stool Antigen Tests Revenue by Application (2021–2026)
5.2.2 Global H. pylori Stool Antigen Tests Revenue by Application (2027–2032)
5.2.3 Global H. pylori Stool Antigen Tests Revenue Market Share by Application (2021–2032)
5.3 Global H. pylori Stool Antigen Tests Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Company Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Abbott Laboratories H. pylori Stool Antigen Tests Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 SD Biosensor, Inc.
6.2.1 SD Biosensor, Inc. Company Information
6.2.2 SD Biosensor, Inc. Description and Business Overview
6.2.3 SD Biosensor, Inc. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 SD Biosensor, Inc. H. pylori Stool Antigen Tests Product Portfolio
6.2.5 SD Biosensor, Inc. Recent Developments/Updates
6.3 SSI Diagnostica A/S
6.3.1 SSI Diagnostica A/S Company Information
6.3.2 SSI Diagnostica A/S Description and Business Overview
6.3.3 SSI Diagnostica A/S H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 SSI Diagnostica A/S H. pylori Stool Antigen Tests Product Portfolio
6.3.5 SSI Diagnostica A/S Recent Developments/Updates
6.4 ACON Laboratories, Inc.
6.4.1 ACON Laboratories, Inc. Company Information
6.4.2 ACON Laboratories, Inc. Description and Business Overview
6.4.3 ACON Laboratories, Inc. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 ACON Laboratories, Inc. H. pylori Stool Antigen Tests Product Portfolio
6.4.5 ACON Laboratories, Inc. Recent Developments/Updates
6.5 Guangzhou Wondfo Biotech Co., Ltd.
6.5.1 Guangzhou Wondfo Biotech Co., Ltd. Company Information
6.5.2 Guangzhou Wondfo Biotech Co., Ltd. Description and Business Overview
6.5.3 Guangzhou Wondfo Biotech Co., Ltd. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Guangzhou Wondfo Biotech Co., Ltd. H. pylori Stool Antigen Tests Product Portfolio
6.5.5 Guangzhou Wondfo Biotech Co., Ltd. Recent Developments/Updates
6.6 Zhejiang Orient Gene Biotech Co., Ltd.
6.6.1 Zhejiang Orient Gene Biotech Co., Ltd. Company Information
6.6.2 Zhejiang Orient Gene Biotech Co., Ltd. Description and Business Overview
6.6.3 Zhejiang Orient Gene Biotech Co., Ltd. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Zhejiang Orient Gene Biotech Co., Ltd. H. pylori Stool Antigen Tests Product Portfolio
6.6.5 Zhejiang Orient Gene Biotech Co., Ltd. Recent Developments/Updates
6.7 HANGZHOU ALLTEST BIOTECH CO., LTD.
6.7.1 HANGZHOU ALLTEST BIOTECH CO., LTD. Company Information
6.7.2 HANGZHOU ALLTEST BIOTECH CO., LTD. Description and Business Overview
6.7.3 HANGZHOU ALLTEST BIOTECH CO., LTD. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 HANGZHOU ALLTEST BIOTECH CO., LTD. H. pylori Stool Antigen Tests Product Portfolio
6.7.5 HANGZHOU ALLTEST BIOTECH CO., LTD. Recent Developments/Updates
6.8 R-Biopharm AG
6.8.1 R-Biopharm AG Company Information
6.8.2 R-Biopharm AG Description and Business Overview
6.8.3 R-Biopharm AG H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 R-Biopharm AG H. pylori Stool Antigen Tests Product Portfolio
6.8.5 R-Biopharm AG Recent Developments/Updates
6.9 Denka Company Limited
6.9.1 Denka Company Limited Company Information
6.9.2 Denka Company Limited Description and Business Overview
6.9.3 Denka Company Limited H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Denka Company Limited H. pylori Stool Antigen Tests Product Portfolio
6.9.5 Denka Company Limited Recent Developments/Updates
6.10 Autobio Diagnostics Co., Ltd.
6.10.1 Autobio Diagnostics Co., Ltd. Company Information
6.10.2 Autobio Diagnostics Co., Ltd. Description and Business Overview
6.10.3 Autobio Diagnostics Co., Ltd. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Autobio Diagnostics Co., Ltd. H. pylori Stool Antigen Tests Product Portfolio
6.10.5 Autobio Diagnostics Co., Ltd. Recent Developments/Updates
6.11 Getein Biotech, Inc.
6.11.1 Getein Biotech, Inc. Company Information
6.11.2 Getein Biotech, Inc. Description and Business Overview
6.11.3 Getein Biotech, Inc. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Getein Biotech, Inc. H. pylori Stool Antigen Tests Product Portfolio
6.11.5 Getein Biotech, Inc. Recent Developments/Updates
6.12 Sentinel Diagnostics
6.12.1 Sentinel Diagnostics Company Information
6.12.2 Sentinel Diagnostics Description and Business Overview
6.12.3 Sentinel Diagnostics H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Sentinel Diagnostics H. pylori Stool Antigen Tests Product Portfolio
6.12.5 Sentinel Diagnostics Recent Developments/Updates
6.13 Boditech Med Inc.
6.13.1 Boditech Med Inc. Company Information
6.13.2 Boditech Med Inc. Description and Business Overview
6.13.3 Boditech Med Inc. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Boditech Med Inc. H. pylori Stool Antigen Tests Product Portfolio
6.13.5 Boditech Med Inc. Recent Developments/Updates
6.14 Certest Biotec, S.L.
6.14.1 Certest Biotec, S.L. Company Information
6.14.2 Certest Biotec, S.L. Description and Business Overview
6.14.3 Certest Biotec, S.L. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Certest Biotec, S.L. H. pylori Stool Antigen Tests Product Portfolio
6.14.5 Certest Biotec, S.L. Recent Developments/Updates
6.15 MIZUHO MEDY Co., Ltd.
6.15.1 MIZUHO MEDY Co., Ltd. Company Information
6.15.2 MIZUHO MEDY Co., Ltd. Description and Business Overview
6.15.3 MIZUHO MEDY Co., Ltd. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 MIZUHO MEDY Co., Ltd. H. pylori Stool Antigen Tests Product Portfolio
6.15.5 MIZUHO MEDY Co., Ltd. Recent Developments/Updates
6.16 Wakamoto Pharmaceutical Co., Ltd.
6.16.1 Wakamoto Pharmaceutical Co., Ltd. Company Information
6.16.2 Wakamoto Pharmaceutical Co., Ltd. Description and Business Overview
6.16.3 Wakamoto Pharmaceutical Co., Ltd. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Wakamoto Pharmaceutical Co., Ltd. H. pylori Stool Antigen Tests Product Portfolio
6.16.5 Wakamoto Pharmaceutical Co., Ltd. Recent Developments/Updates
6.17 Humasis Co., Ltd.
6.17.1 Humasis Co., Ltd. Company Information
6.17.2 Humasis Co., Ltd. Description and Business Overview
6.17.3 Humasis Co., Ltd. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Humasis Co., Ltd. H. pylori Stool Antigen Tests Product Portfolio
6.17.5 Humasis Co., Ltd. Recent Developments/Updates
6.18 Innovita Biological Technology Co., Ltd.
6.18.1 Innovita Biological Technology Co., Ltd. Company Information
6.18.2 Innovita Biological Technology Co., Ltd. Description and Business Overview
6.18.3 Innovita Biological Technology Co., Ltd. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Innovita Biological Technology Co., Ltd. H. pylori Stool Antigen Tests Product Portfolio
6.18.5 Innovita Biological Technology Co., Ltd. Recent Developments/Updates
6.19 Assure Tech Hangzhou Co., Ltd.
6.19.1 Assure Tech Hangzhou Co., Ltd. Company Information
6.19.2 Assure Tech Hangzhou Co., Ltd. Description and Business Overview
6.19.3 Assure Tech Hangzhou Co., Ltd. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Assure Tech Hangzhou Co., Ltd. H. pylori Stool Antigen Tests Product Portfolio
6.19.5 Assure Tech Hangzhou Co., Ltd. Recent Developments/Updates
6.20 Trinity Biotech plc
6.20.1 Trinity Biotech plc Company Information
6.20.2 Trinity Biotech plc Description and Business Overview
6.20.3 Trinity Biotech plc H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Trinity Biotech plc H. pylori Stool Antigen Tests Product Portfolio
6.20.5 Trinity Biotech plc Recent Developments/Updates
6.21 Savyon Diagnostics Ltd.
6.21.1 Savyon Diagnostics Ltd. Company Information
6.21.2 Savyon Diagnostics Ltd. Description and Business Overview
6.21.3 Savyon Diagnostics Ltd. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Savyon Diagnostics Ltd. H. pylori Stool Antigen Tests Product Portfolio
6.21.5 Savyon Diagnostics Ltd. Recent Developments/Updates
6.22 nal von minden GmbH
6.22.1 nal von minden GmbH Company Information
6.22.2 nal von minden GmbH Description and Business Overview
6.22.3 nal von minden GmbH H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 nal von minden GmbH H. pylori Stool Antigen Tests Product Portfolio
6.22.5 nal von minden GmbH Recent Developments/Updates
6.23 DIALAB GmbH
6.23.1 DIALAB GmbH Company Information
6.23.2 DIALAB GmbH Description and Business Overview
6.23.3 DIALAB GmbH H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 DIALAB GmbH H. pylori Stool Antigen Tests Product Portfolio
6.23.5 DIALAB GmbH Recent Developments/Updates
6.24 Biopanda Reagents Ltd.
6.24.1 Biopanda Reagents Ltd. Company Information
6.24.2 Biopanda Reagents Ltd. Description and Business Overview
6.24.3 Biopanda Reagents Ltd. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.24.4 Biopanda Reagents Ltd. H. pylori Stool Antigen Tests Product Portfolio
6.24.5 Biopanda Reagents Ltd. Recent Developments/Updates
6.25 Apacor Limited
6.25.1 Apacor Limited Company Information
6.25.2 Apacor Limited Description and Business Overview
6.25.3 Apacor Limited H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.25.4 Apacor Limited H. pylori Stool Antigen Tests Product Portfolio
6.25.5 Apacor Limited Recent Developments/Updates
6.26 Panion & BF Biotech, Inc.
6.26.1 Panion & BF Biotech, Inc. Company Information
6.26.2 Panion & BF Biotech, Inc. Description and Business Overview
6.26.3 Panion & BF Biotech, Inc. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.26.4 Panion & BF Biotech, Inc. H. pylori Stool Antigen Tests Product Portfolio
6.26.5 Panion & BF Biotech, Inc. Recent Developments/Updates
6.27 STRONG BIOTECH CORPORATION
6.27.1 STRONG BIOTECH CORPORATION Company Information
6.27.2 STRONG BIOTECH CORPORATION Description and Business Overview
6.27.3 STRONG BIOTECH CORPORATION H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.27.4 STRONG BIOTECH CORPORATION H. pylori Stool Antigen Tests Product Portfolio
6.27.5 STRONG BIOTECH CORPORATION Recent Developments/Updates
6.28 Beijing Lepu Diagnostics Technology Co., Ltd.
6.28.1 Beijing Lepu Diagnostics Technology Co., Ltd. Company Information
6.28.2 Beijing Lepu Diagnostics Technology Co., Ltd. Description and Business Overview
6.28.3 Beijing Lepu Diagnostics Technology Co., Ltd. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.28.4 Beijing Lepu Diagnostics Technology Co., Ltd. H. pylori Stool Antigen Tests Product Portfolio
6.28.5 Beijing Lepu Diagnostics Technology Co., Ltd. Recent Developments/Updates
6.29 Cofoe Medical Technology Co., Ltd.
6.29.1 Cofoe Medical Technology Co., Ltd. Company Information
6.29.2 Cofoe Medical Technology Co., Ltd. Description and Business Overview
6.29.3 Cofoe Medical Technology Co., Ltd. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.29.4 Cofoe Medical Technology Co., Ltd. H. pylori Stool Antigen Tests Product Portfolio
6.29.5 Cofoe Medical Technology Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 H. pylori Stool Antigen Tests Industry Chain Analysis
7.2 H. pylori Stool Antigen Tests Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 H. pylori Stool Antigen Tests Production Mode & Process Analysis
7.4 H. pylori Stool Antigen Tests Sales and Marketing
7.4.1 H. pylori Stool Antigen Tests Sales Channels
7.4.2 H. pylori Stool Antigen Tests Distributors
7.5 H. pylori Stool Antigen Tests Customer Analysis
8 H. pylori Stool Antigen Tests Market Dynamics
8.1 H. pylori Stool Antigen Tests Industry Trends
8.2 H. pylori Stool Antigen Tests Market Drivers
8.3 H. pylori Stool Antigen Tests Market Challenges
8.4 H. pylori Stool Antigen Tests Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 H. pylori Stool Antigen Tests by Type
1.2.1 Global H. pylori Stool Antigen Tests Market Value by Type: 2025 vs 2032
1.2.2 Lateral Flow Immunochromatography
1.2.3 Fluorescence Immunoassay
1.2.4 Enzyme Immunoassay
1.2.5 Chemiluminescence Immunoassay
1.2.6 Latex Turbidimetric Immunoassay
1.2.7 Other
1.3 H. pylori Stool Antigen Tests by Operating Format
1.3.1 Global H. pylori Stool Antigen Tests Market Value by Operating Format: 2025 vs 2032
1.3.2 Visual Cassette
1.3.3 Reader Assisted Cassette
1.3.4 Microplate Kit
1.3.5 Automated Analyzer Reagent
1.3.6 Other
1.4 H. pylori Stool Antigen Tests by Application
1.4.1 Global H. pylori Stool Antigen Tests Market Value by Application: 2025 vs 2032
1.4.2 Home Self-Testing
1.4.3 Primary Care Clinic Testing
1.4.4 Gastroenterology Clinic Testing
1.4.5 Hospital Point-of-Care Testing
1.4.6 Hospital Central Laboratory Testing
1.4.7 Independent Reference Laboratory Testing
1.4.8 Other
1.5 Global H. pylori Stool Antigen Tests Market Size Estimates and Forecasts
1.5.1 Global H. pylori Stool Antigen Tests Revenue 2021–2032
1.5.2 Global H. pylori Stool Antigen Tests Sales 2021–2032
1.5.3 Global H. pylori Stool Antigen Tests Market Average Price (2021–2032)
1.6 Assumptions and Limitations
2 H. pylori Stool Antigen Tests Market Competition by Manufacturers
2.1 Global H. pylori Stool Antigen Tests Sales Market Share by Manufacturers (2021–2026)
2.2 Global H. pylori Stool Antigen Tests Revenue Market Share by Manufacturers (2021–2026)
2.3 Global H. pylori Stool Antigen Tests Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of H. pylori Stool Antigen Tests, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of H. pylori Stool Antigen Tests, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of H. pylori Stool Antigen Tests, Product Types and Applications
2.7 Global Key Manufacturers of H. pylori Stool Antigen Tests, Date of Entry into the Industry
2.8 Global H. pylori Stool Antigen Tests Market Competitive Situation and Trends
2.8.1 Global H. pylori Stool Antigen Tests Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global H. pylori Stool Antigen Tests Players Market Share by Revenue
2.8.3 Global H. pylori Stool Antigen Tests Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global H. pylori Stool Antigen Tests Market Scenario by Region
3.1 Global H. pylori Stool Antigen Tests Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global H. pylori Stool Antigen Tests Sales by Region: 2021–2032
3.2.1 Global H. pylori Stool Antigen Tests Sales by Region: 2021–2026
3.2.2 Global H. pylori Stool Antigen Tests Sales by Region: 2027–2032
3.3 Global H. pylori Stool Antigen Tests Revenue by Region: 2021–2032
3.3.1 Global H. pylori Stool Antigen Tests Revenue by Region: 2021–2026
3.3.2 Global H. pylori Stool Antigen Tests Revenue by Region: 2027–2032
3.4 North America H. pylori Stool Antigen Tests Market Facts & Figures by Country
3.4.1 North America H. pylori Stool Antigen Tests Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America H. pylori Stool Antigen Tests Sales by Country (2021–2032)
3.4.3 North America H. pylori Stool Antigen Tests Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe H. pylori Stool Antigen Tests Market Facts & Figures by Country
3.5.1 Europe H. pylori Stool Antigen Tests Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe H. pylori Stool Antigen Tests Sales by Country (2021–2032)
3.5.3 Europe H. pylori Stool Antigen Tests Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific H. pylori Stool Antigen Tests Market Facts & Figures by Region
3.6.1 Asia Pacific H. pylori Stool Antigen Tests Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific H. pylori Stool Antigen Tests Sales by Region (2021–2032)
3.6.3 Asia Pacific H. pylori Stool Antigen Tests Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America H. pylori Stool Antigen Tests Market Facts & Figures by Country
3.7.1 Latin America H. pylori Stool Antigen Tests Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America H. pylori Stool Antigen Tests Sales by Country (2021–2032)
3.7.3 Latin America H. pylori Stool Antigen Tests Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa H. pylori Stool Antigen Tests Market Facts & Figures by Country
3.8.1 Middle East and Africa H. pylori Stool Antigen Tests Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa H. pylori Stool Antigen Tests Sales by Country (2021–2032)
3.8.3 Middle East and Africa H. pylori Stool Antigen Tests Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global H. pylori Stool Antigen Tests Sales by Type (2021–2032)
4.1.1 Global H. pylori Stool Antigen Tests Sales by Type (2021–2026)
4.1.2 Global H. pylori Stool Antigen Tests Sales by Type (2027–2032)
4.1.3 Global H. pylori Stool Antigen Tests Sales Market Share by Type (2021–2032)
4.2 Global H. pylori Stool Antigen Tests Revenue by Type (2021–2032)
4.2.1 Global H. pylori Stool Antigen Tests Revenue by Type (2021–2026)
4.2.2 Global H. pylori Stool Antigen Tests Revenue by Type (2027–2032)
4.2.3 Global H. pylori Stool Antigen Tests Revenue Market Share by Type (2021–2032)
4.3 Global H. pylori Stool Antigen Tests Price by Type (2021–2032)
5 Segment by Application
5.1 Global H. pylori Stool Antigen Tests Sales by Application (2021–2032)
5.1.1 Global H. pylori Stool Antigen Tests Sales by Application (2021–2026)
5.1.2 Global H. pylori Stool Antigen Tests Sales by Application (2027–2032)
5.1.3 Global H. pylori Stool Antigen Tests Sales Market Share by Application (2021–2032)
5.2 Global H. pylori Stool Antigen Tests Revenue by Application (2021–2032)
5.2.1 Global H. pylori Stool Antigen Tests Revenue by Application (2021–2026)
5.2.2 Global H. pylori Stool Antigen Tests Revenue by Application (2027–2032)
5.2.3 Global H. pylori Stool Antigen Tests Revenue Market Share by Application (2021–2032)
5.3 Global H. pylori Stool Antigen Tests Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Company Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Abbott Laboratories H. pylori Stool Antigen Tests Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 SD Biosensor, Inc.
6.2.1 SD Biosensor, Inc. Company Information
6.2.2 SD Biosensor, Inc. Description and Business Overview
6.2.3 SD Biosensor, Inc. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 SD Biosensor, Inc. H. pylori Stool Antigen Tests Product Portfolio
6.2.5 SD Biosensor, Inc. Recent Developments/Updates
6.3 SSI Diagnostica A/S
6.3.1 SSI Diagnostica A/S Company Information
6.3.2 SSI Diagnostica A/S Description and Business Overview
6.3.3 SSI Diagnostica A/S H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 SSI Diagnostica A/S H. pylori Stool Antigen Tests Product Portfolio
6.3.5 SSI Diagnostica A/S Recent Developments/Updates
6.4 ACON Laboratories, Inc.
6.4.1 ACON Laboratories, Inc. Company Information
6.4.2 ACON Laboratories, Inc. Description and Business Overview
6.4.3 ACON Laboratories, Inc. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 ACON Laboratories, Inc. H. pylori Stool Antigen Tests Product Portfolio
6.4.5 ACON Laboratories, Inc. Recent Developments/Updates
6.5 Guangzhou Wondfo Biotech Co., Ltd.
6.5.1 Guangzhou Wondfo Biotech Co., Ltd. Company Information
6.5.2 Guangzhou Wondfo Biotech Co., Ltd. Description and Business Overview
6.5.3 Guangzhou Wondfo Biotech Co., Ltd. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Guangzhou Wondfo Biotech Co., Ltd. H. pylori Stool Antigen Tests Product Portfolio
6.5.5 Guangzhou Wondfo Biotech Co., Ltd. Recent Developments/Updates
6.6 Zhejiang Orient Gene Biotech Co., Ltd.
6.6.1 Zhejiang Orient Gene Biotech Co., Ltd. Company Information
6.6.2 Zhejiang Orient Gene Biotech Co., Ltd. Description and Business Overview
6.6.3 Zhejiang Orient Gene Biotech Co., Ltd. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Zhejiang Orient Gene Biotech Co., Ltd. H. pylori Stool Antigen Tests Product Portfolio
6.6.5 Zhejiang Orient Gene Biotech Co., Ltd. Recent Developments/Updates
6.7 HANGZHOU ALLTEST BIOTECH CO., LTD.
6.7.1 HANGZHOU ALLTEST BIOTECH CO., LTD. Company Information
6.7.2 HANGZHOU ALLTEST BIOTECH CO., LTD. Description and Business Overview
6.7.3 HANGZHOU ALLTEST BIOTECH CO., LTD. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 HANGZHOU ALLTEST BIOTECH CO., LTD. H. pylori Stool Antigen Tests Product Portfolio
6.7.5 HANGZHOU ALLTEST BIOTECH CO., LTD. Recent Developments/Updates
6.8 R-Biopharm AG
6.8.1 R-Biopharm AG Company Information
6.8.2 R-Biopharm AG Description and Business Overview
6.8.3 R-Biopharm AG H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 R-Biopharm AG H. pylori Stool Antigen Tests Product Portfolio
6.8.5 R-Biopharm AG Recent Developments/Updates
6.9 Denka Company Limited
6.9.1 Denka Company Limited Company Information
6.9.2 Denka Company Limited Description and Business Overview
6.9.3 Denka Company Limited H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Denka Company Limited H. pylori Stool Antigen Tests Product Portfolio
6.9.5 Denka Company Limited Recent Developments/Updates
6.10 Autobio Diagnostics Co., Ltd.
6.10.1 Autobio Diagnostics Co., Ltd. Company Information
6.10.2 Autobio Diagnostics Co., Ltd. Description and Business Overview
6.10.3 Autobio Diagnostics Co., Ltd. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Autobio Diagnostics Co., Ltd. H. pylori Stool Antigen Tests Product Portfolio
6.10.5 Autobio Diagnostics Co., Ltd. Recent Developments/Updates
6.11 Getein Biotech, Inc.
6.11.1 Getein Biotech, Inc. Company Information
6.11.2 Getein Biotech, Inc. Description and Business Overview
6.11.3 Getein Biotech, Inc. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Getein Biotech, Inc. H. pylori Stool Antigen Tests Product Portfolio
6.11.5 Getein Biotech, Inc. Recent Developments/Updates
6.12 Sentinel Diagnostics
6.12.1 Sentinel Diagnostics Company Information
6.12.2 Sentinel Diagnostics Description and Business Overview
6.12.3 Sentinel Diagnostics H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Sentinel Diagnostics H. pylori Stool Antigen Tests Product Portfolio
6.12.5 Sentinel Diagnostics Recent Developments/Updates
6.13 Boditech Med Inc.
6.13.1 Boditech Med Inc. Company Information
6.13.2 Boditech Med Inc. Description and Business Overview
6.13.3 Boditech Med Inc. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Boditech Med Inc. H. pylori Stool Antigen Tests Product Portfolio
6.13.5 Boditech Med Inc. Recent Developments/Updates
6.14 Certest Biotec, S.L.
6.14.1 Certest Biotec, S.L. Company Information
6.14.2 Certest Biotec, S.L. Description and Business Overview
6.14.3 Certest Biotec, S.L. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Certest Biotec, S.L. H. pylori Stool Antigen Tests Product Portfolio
6.14.5 Certest Biotec, S.L. Recent Developments/Updates
6.15 MIZUHO MEDY Co., Ltd.
6.15.1 MIZUHO MEDY Co., Ltd. Company Information
6.15.2 MIZUHO MEDY Co., Ltd. Description and Business Overview
6.15.3 MIZUHO MEDY Co., Ltd. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 MIZUHO MEDY Co., Ltd. H. pylori Stool Antigen Tests Product Portfolio
6.15.5 MIZUHO MEDY Co., Ltd. Recent Developments/Updates
6.16 Wakamoto Pharmaceutical Co., Ltd.
6.16.1 Wakamoto Pharmaceutical Co., Ltd. Company Information
6.16.2 Wakamoto Pharmaceutical Co., Ltd. Description and Business Overview
6.16.3 Wakamoto Pharmaceutical Co., Ltd. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Wakamoto Pharmaceutical Co., Ltd. H. pylori Stool Antigen Tests Product Portfolio
6.16.5 Wakamoto Pharmaceutical Co., Ltd. Recent Developments/Updates
6.17 Humasis Co., Ltd.
6.17.1 Humasis Co., Ltd. Company Information
6.17.2 Humasis Co., Ltd. Description and Business Overview
6.17.3 Humasis Co., Ltd. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Humasis Co., Ltd. H. pylori Stool Antigen Tests Product Portfolio
6.17.5 Humasis Co., Ltd. Recent Developments/Updates
6.18 Innovita Biological Technology Co., Ltd.
6.18.1 Innovita Biological Technology Co., Ltd. Company Information
6.18.2 Innovita Biological Technology Co., Ltd. Description and Business Overview
6.18.3 Innovita Biological Technology Co., Ltd. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Innovita Biological Technology Co., Ltd. H. pylori Stool Antigen Tests Product Portfolio
6.18.5 Innovita Biological Technology Co., Ltd. Recent Developments/Updates
6.19 Assure Tech Hangzhou Co., Ltd.
6.19.1 Assure Tech Hangzhou Co., Ltd. Company Information
6.19.2 Assure Tech Hangzhou Co., Ltd. Description and Business Overview
6.19.3 Assure Tech Hangzhou Co., Ltd. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Assure Tech Hangzhou Co., Ltd. H. pylori Stool Antigen Tests Product Portfolio
6.19.5 Assure Tech Hangzhou Co., Ltd. Recent Developments/Updates
6.20 Trinity Biotech plc
6.20.1 Trinity Biotech plc Company Information
6.20.2 Trinity Biotech plc Description and Business Overview
6.20.3 Trinity Biotech plc H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Trinity Biotech plc H. pylori Stool Antigen Tests Product Portfolio
6.20.5 Trinity Biotech plc Recent Developments/Updates
6.21 Savyon Diagnostics Ltd.
6.21.1 Savyon Diagnostics Ltd. Company Information
6.21.2 Savyon Diagnostics Ltd. Description and Business Overview
6.21.3 Savyon Diagnostics Ltd. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Savyon Diagnostics Ltd. H. pylori Stool Antigen Tests Product Portfolio
6.21.5 Savyon Diagnostics Ltd. Recent Developments/Updates
6.22 nal von minden GmbH
6.22.1 nal von minden GmbH Company Information
6.22.2 nal von minden GmbH Description and Business Overview
6.22.3 nal von minden GmbH H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 nal von minden GmbH H. pylori Stool Antigen Tests Product Portfolio
6.22.5 nal von minden GmbH Recent Developments/Updates
6.23 DIALAB GmbH
6.23.1 DIALAB GmbH Company Information
6.23.2 DIALAB GmbH Description and Business Overview
6.23.3 DIALAB GmbH H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 DIALAB GmbH H. pylori Stool Antigen Tests Product Portfolio
6.23.5 DIALAB GmbH Recent Developments/Updates
6.24 Biopanda Reagents Ltd.
6.24.1 Biopanda Reagents Ltd. Company Information
6.24.2 Biopanda Reagents Ltd. Description and Business Overview
6.24.3 Biopanda Reagents Ltd. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.24.4 Biopanda Reagents Ltd. H. pylori Stool Antigen Tests Product Portfolio
6.24.5 Biopanda Reagents Ltd. Recent Developments/Updates
6.25 Apacor Limited
6.25.1 Apacor Limited Company Information
6.25.2 Apacor Limited Description and Business Overview
6.25.3 Apacor Limited H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.25.4 Apacor Limited H. pylori Stool Antigen Tests Product Portfolio
6.25.5 Apacor Limited Recent Developments/Updates
6.26 Panion & BF Biotech, Inc.
6.26.1 Panion & BF Biotech, Inc. Company Information
6.26.2 Panion & BF Biotech, Inc. Description and Business Overview
6.26.3 Panion & BF Biotech, Inc. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.26.4 Panion & BF Biotech, Inc. H. pylori Stool Antigen Tests Product Portfolio
6.26.5 Panion & BF Biotech, Inc. Recent Developments/Updates
6.27 STRONG BIOTECH CORPORATION
6.27.1 STRONG BIOTECH CORPORATION Company Information
6.27.2 STRONG BIOTECH CORPORATION Description and Business Overview
6.27.3 STRONG BIOTECH CORPORATION H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.27.4 STRONG BIOTECH CORPORATION H. pylori Stool Antigen Tests Product Portfolio
6.27.5 STRONG BIOTECH CORPORATION Recent Developments/Updates
6.28 Beijing Lepu Diagnostics Technology Co., Ltd.
6.28.1 Beijing Lepu Diagnostics Technology Co., Ltd. Company Information
6.28.2 Beijing Lepu Diagnostics Technology Co., Ltd. Description and Business Overview
6.28.3 Beijing Lepu Diagnostics Technology Co., Ltd. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.28.4 Beijing Lepu Diagnostics Technology Co., Ltd. H. pylori Stool Antigen Tests Product Portfolio
6.28.5 Beijing Lepu Diagnostics Technology Co., Ltd. Recent Developments/Updates
6.29 Cofoe Medical Technology Co., Ltd.
6.29.1 Cofoe Medical Technology Co., Ltd. Company Information
6.29.2 Cofoe Medical Technology Co., Ltd. Description and Business Overview
6.29.3 Cofoe Medical Technology Co., Ltd. H. pylori Stool Antigen Tests Sales, Revenue, and Gross Margin (2021–2026)
6.29.4 Cofoe Medical Technology Co., Ltd. H. pylori Stool Antigen Tests Product Portfolio
6.29.5 Cofoe Medical Technology Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 H. pylori Stool Antigen Tests Industry Chain Analysis
7.2 H. pylori Stool Antigen Tests Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 H. pylori Stool Antigen Tests Production Mode & Process Analysis
7.4 H. pylori Stool Antigen Tests Sales and Marketing
7.4.1 H. pylori Stool Antigen Tests Sales Channels
7.4.2 H. pylori Stool Antigen Tests Distributors
7.5 H. pylori Stool Antigen Tests Customer Analysis
8 H. pylori Stool Antigen Tests Market Dynamics
8.1 H. pylori Stool Antigen Tests Industry Trends
8.2 H. pylori Stool Antigen Tests Market Drivers
8.3 H. pylori Stool Antigen Tests Market Challenges
8.4 H. pylori Stool Antigen Tests Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global H. pylori Stool Antigen Tests Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global H. pylori Stool Antigen Tests Market Value by Operating Format (US$ Million), 2025 vs 2032
Table 3. Global H. pylori Stool Antigen Tests Market Value by Application (US$ Million), 2025 vs 2032
Table 4. Global H. pylori Stool Antigen Tests Market Competitive Situation by Manufacturers in 2025
Table 5. Global H. pylori Stool Antigen Tests Sales (Units) of Key Manufacturers (2021–2026)
Table 6. Global H. pylori Stool Antigen Tests Sales Market Share by Manufacturers (2021–2026)
Table 7. Global H. pylori Stool Antigen Tests Revenue (US$ Million) by Manufacturers (2021–2026)
Table 8. Global H. pylori Stool Antigen Tests Revenue Share by Manufacturers (2021–2026)
Table 9. Global Market H. pylori Stool Antigen Tests Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 10. Global Key Players of H. pylori Stool Antigen Tests, Industry Ranking, 2023 vs 2024 vs 2025
Table 11. Global Key Manufacturers of H. pylori Stool Antigen Tests, Manufacturing Sites and Headquarters
Table 12. Global Key Manufacturers of H. pylori Stool Antigen Tests, Product Types and Applications
Table 13. Global Key Manufacturers of H. pylori Stool Antigen Tests, Date of Entry into the Industry
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global H. pylori Stool Antigen Tests Companies by Tier (Tier 1, Tier 2, Tier 3), based on H. pylori Stool Antigen Tests Revenue, 2025
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Global H. pylori Stool Antigen Tests Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 18. Global H. pylori Stool Antigen Tests Sales by Region (Units), 2021–2026
Table 19. Global H. pylori Stool Antigen Tests Sales Market Share by Region (2021–2026)
Table 20. Global H. pylori Stool Antigen Tests Sales by Region (Units), 2027–2032
Table 21. Global H. pylori Stool Antigen Tests Sales Market Share by Region (2027–2032)
Table 22. Global H. pylori Stool Antigen Tests Revenue by Region (US$ Million), 2021–2026
Table 23. Global H. pylori Stool Antigen Tests Revenue Market Share by Region (2021–2026)
Table 24. Global H. pylori Stool Antigen Tests Revenue by Region (US$ Million), 2027–2032
Table 25. Global H. pylori Stool Antigen Tests Revenue Market Share by Region (2027–2032)
Table 26. North America H. pylori Stool Antigen Tests Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 27. North America H. pylori Stool Antigen Tests Sales by Country (Units), 2021–2026
Table 28. North America H. pylori Stool Antigen Tests Sales by Country (Units), 2027–2032
Table 29. North America H. pylori Stool Antigen Tests Revenue by Country (US$ Million), 2021–2026
Table 30. North America H. pylori Stool Antigen Tests Revenue by Country (US$ Million), 2027–2032
Table 31. Europe H. pylori Stool Antigen Tests Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 32. Europe H. pylori Stool Antigen Tests Sales by Country (Units), 2021–2026
Table 33. Europe H. pylori Stool Antigen Tests Sales by Country (Units), 2027–2032
Table 34. Europe H. pylori Stool Antigen Tests Revenue by Country (US$ Million), 2021–2026
Table 35. Europe H. pylori Stool Antigen Tests Revenue by Country (US$ Million), 2027–2032
Table 36. Asia Pacific H. pylori Stool Antigen Tests Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 37. Asia Pacific H. pylori Stool Antigen Tests Sales by Region (Units), 2021–2026
Table 38. Asia Pacific H. pylori Stool Antigen Tests Sales by Region (Units), 2027–2032
Table 39. Asia Pacific H. pylori Stool Antigen Tests Revenue by Region (US$ Million), 2021–2026
Table 40. Asia Pacific H. pylori Stool Antigen Tests Revenue by Region (US$ Million), 2027–2032
Table 41. Latin America H. pylori Stool Antigen Tests Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 42. Latin America H. pylori Stool Antigen Tests Sales by Country (Units), 2021–2026
Table 43. Latin America H. pylori Stool Antigen Tests Sales by Country (Units), 2027–2032
Table 44. Latin America H. pylori Stool Antigen Tests Revenue by Country (US$ Million), 2021–2026
Table 45. Latin America H. pylori Stool Antigen Tests Revenue by Country (US$ Million), 2027–2032
Table 46. Middle East and Africa H. pylori Stool Antigen Tests Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 47. Middle East and Africa H. pylori Stool Antigen Tests Sales by Country (Units), 2021–2026
Table 48. Middle East and Africa H. pylori Stool Antigen Tests Sales by Country (Units), 2027–2032
Table 49. Middle East and Africa H. pylori Stool Antigen Tests Revenue by Country (US$ Million), 2021–2026
Table 50. Middle East and Africa H. pylori Stool Antigen Tests Revenue by Country (US$ Million), 2027–2032
Table 51. Global H. pylori Stool Antigen Tests Sales (Units) by Type (2021–2026)
Table 52. Global H. pylori Stool Antigen Tests Sales (Units) by Type (2027–2032)
Table 53. Global H. pylori Stool Antigen Tests Sales Market Share by Type (2021–2026)
Table 54. Global H. pylori Stool Antigen Tests Sales Market Share by Type (2027–2032)
Table 55. Global H. pylori Stool Antigen Tests Revenue (US$ Million) by Type (2021–2026)
Table 56. Global H. pylori Stool Antigen Tests Revenue (US$ Million) by Type (2027–2032)
Table 57. Global H. pylori Stool Antigen Tests Revenue Market Share by Type (2021–2026)
Table 58. Global H. pylori Stool Antigen Tests Revenue Market Share by Type (2027–2032)
Table 59. Global H. pylori Stool Antigen Tests Price (US$/Unit) by Type (2021–2026)
Table 60. Global H. pylori Stool Antigen Tests Price (US$/Unit) by Type (2027–2032)
Table 61. Global H. pylori Stool Antigen Tests Sales (Units) by Application (2021–2026)
Table 62. Global H. pylori Stool Antigen Tests Sales (Units) by Application (2027–2032)
Table 63. Global H. pylori Stool Antigen Tests Sales Market Share by Application (2021–2026)
Table 64. Global H. pylori Stool Antigen Tests Sales Market Share by Application (2027–2032)
Table 65. Global H. pylori Stool Antigen Tests Revenue (US$ Million) by Application (2021–2026)
Table 66. Global H. pylori Stool Antigen Tests Revenue (US$ Million) by Application (2027–2032)
Table 67. Global H. pylori Stool Antigen Tests Revenue Market Share by Application (2021–2026)
Table 68. Global H. pylori Stool Antigen Tests Revenue Market Share by Application (2027–2032)
Table 69. Global H. pylori Stool Antigen Tests Price (US$/Unit) by Application (2021–2026)
Table 70. Global H. pylori Stool Antigen Tests Price (US$/Unit) by Application (2027–2032)
Table 71. Abbott Laboratories Company Information
Table 72. Abbott Laboratories Description and Business Overview
Table 73. Abbott Laboratories H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 74. Abbott Laboratories H. pylori Stool Antigen Tests Product
Table 75. Abbott Laboratories Recent Developments/Updates
Table 76. SD Biosensor, Inc. Company Information
Table 77. SD Biosensor, Inc. Description and Business Overview
Table 78. SD Biosensor, Inc. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 79. SD Biosensor, Inc. H. pylori Stool Antigen Tests Product
Table 80. SD Biosensor, Inc. Recent Developments/Updates
Table 81. SSI Diagnostica A/S Company Information
Table 82. SSI Diagnostica A/S Description and Business Overview
Table 83. SSI Diagnostica A/S H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 84. SSI Diagnostica A/S H. pylori Stool Antigen Tests Product
Table 85. SSI Diagnostica A/S Recent Developments/Updates
Table 86. ACON Laboratories, Inc. Company Information
Table 87. ACON Laboratories, Inc. Description and Business Overview
Table 88. ACON Laboratories, Inc. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 89. ACON Laboratories, Inc. H. pylori Stool Antigen Tests Product
Table 90. ACON Laboratories, Inc. Recent Developments/Updates
Table 91. Guangzhou Wondfo Biotech Co., Ltd. Company Information
Table 92. Guangzhou Wondfo Biotech Co., Ltd. Description and Business Overview
Table 93. Guangzhou Wondfo Biotech Co., Ltd. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 94. Guangzhou Wondfo Biotech Co., Ltd. H. pylori Stool Antigen Tests Product
Table 95. Guangzhou Wondfo Biotech Co., Ltd. Recent Developments/Updates
Table 96. Zhejiang Orient Gene Biotech Co., Ltd. Company Information
Table 97. Zhejiang Orient Gene Biotech Co., Ltd. Description and Business Overview
Table 98. Zhejiang Orient Gene Biotech Co., Ltd. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 99. Zhejiang Orient Gene Biotech Co., Ltd. H. pylori Stool Antigen Tests Product
Table 100. Zhejiang Orient Gene Biotech Co., Ltd. Recent Developments/Updates
Table 101. HANGZHOU ALLTEST BIOTECH CO., LTD. Company Information
Table 102. HANGZHOU ALLTEST BIOTECH CO., LTD. Description and Business Overview
Table 103. HANGZHOU ALLTEST BIOTECH CO., LTD. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 104. HANGZHOU ALLTEST BIOTECH CO., LTD. H. pylori Stool Antigen Tests Product
Table 105. HANGZHOU ALLTEST BIOTECH CO., LTD. Recent Developments/Updates
Table 106. R-Biopharm AG Company Information
Table 107. R-Biopharm AG Description and Business Overview
Table 108. R-Biopharm AG H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 109. R-Biopharm AG H. pylori Stool Antigen Tests Product
Table 110. R-Biopharm AG Recent Developments/Updates
Table 111. Denka Company Limited Company Information
Table 112. Denka Company Limited Description and Business Overview
Table 113. Denka Company Limited H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 114. Denka Company Limited H. pylori Stool Antigen Tests Product
Table 115. Denka Company Limited Recent Developments/Updates
Table 116. Autobio Diagnostics Co., Ltd. Company Information
Table 117. Autobio Diagnostics Co., Ltd. Description and Business Overview
Table 118. Autobio Diagnostics Co., Ltd. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 119. Autobio Diagnostics Co., Ltd. H. pylori Stool Antigen Tests Product
Table 120. Autobio Diagnostics Co., Ltd. Recent Developments/Updates
Table 121. Getein Biotech, Inc. Company Information
Table 122. Getein Biotech, Inc. Description and Business Overview
Table 123. Getein Biotech, Inc. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 124. Getein Biotech, Inc. H. pylori Stool Antigen Tests Product
Table 125. Getein Biotech, Inc. Recent Developments/Updates
Table 126. Sentinel Diagnostics Company Information
Table 127. Sentinel Diagnostics Description and Business Overview
Table 128. Sentinel Diagnostics H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 129. Sentinel Diagnostics H. pylori Stool Antigen Tests Product
Table 130. Sentinel Diagnostics Recent Developments/Updates
Table 131. Boditech Med Inc. Company Information
Table 132. Boditech Med Inc. Description and Business Overview
Table 133. Boditech Med Inc. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 134. Boditech Med Inc. H. pylori Stool Antigen Tests Product
Table 135. Boditech Med Inc. Recent Developments/Updates
Table 136. Certest Biotec, S.L. Company Information
Table 137. Certest Biotec, S.L. Description and Business Overview
Table 138. Certest Biotec, S.L. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 139. Certest Biotec, S.L. H. pylori Stool Antigen Tests Product
Table 140. Certest Biotec, S.L. Recent Developments/Updates
Table 141. MIZUHO MEDY Co., Ltd. Company Information
Table 142. MIZUHO MEDY Co., Ltd. Description and Business Overview
Table 143. MIZUHO MEDY Co., Ltd. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 144. MIZUHO MEDY Co., Ltd. H. pylori Stool Antigen Tests Product
Table 145. MIZUHO MEDY Co., Ltd. Recent Developments/Updates
Table 146. Wakamoto Pharmaceutical Co., Ltd. Company Information
Table 147. Wakamoto Pharmaceutical Co., Ltd. Description and Business Overview
Table 148. Wakamoto Pharmaceutical Co., Ltd. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 149. Wakamoto Pharmaceutical Co., Ltd. H. pylori Stool Antigen Tests Product
Table 150. Wakamoto Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 151. Humasis Co., Ltd. Company Information
Table 152. Humasis Co., Ltd. Description and Business Overview
Table 153. Humasis Co., Ltd. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 154. Humasis Co., Ltd. H. pylori Stool Antigen Tests Product
Table 155. Humasis Co., Ltd. Recent Developments/Updates
Table 156. Innovita Biological Technology Co., Ltd. Company Information
Table 157. Innovita Biological Technology Co., Ltd. Description and Business Overview
Table 158. Innovita Biological Technology Co., Ltd. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 159. Innovita Biological Technology Co., Ltd. H. pylori Stool Antigen Tests Product
Table 160. Innovita Biological Technology Co., Ltd. Recent Developments/Updates
Table 161. Assure Tech Hangzhou Co., Ltd. Company Information
Table 162. Assure Tech Hangzhou Co., Ltd. Description and Business Overview
Table 163. Assure Tech Hangzhou Co., Ltd. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 164. Assure Tech Hangzhou Co., Ltd. H. pylori Stool Antigen Tests Product
Table 165. Assure Tech Hangzhou Co., Ltd. Recent Developments/Updates
Table 166. Trinity Biotech plc Company Information
Table 167. Trinity Biotech plc Description and Business Overview
Table 168. Trinity Biotech plc H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 169. Trinity Biotech plc H. pylori Stool Antigen Tests Product
Table 170. Trinity Biotech plc Recent Developments/Updates
Table 171. Savyon Diagnostics Ltd. Company Information
Table 172. Savyon Diagnostics Ltd. Description and Business Overview
Table 173. Savyon Diagnostics Ltd. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 174. Savyon Diagnostics Ltd. H. pylori Stool Antigen Tests Product
Table 175. Savyon Diagnostics Ltd. Recent Developments/Updates
Table 176. nal von minden GmbH Company Information
Table 177. nal von minden GmbH Description and Business Overview
Table 178. nal von minden GmbH H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 179. nal von minden GmbH H. pylori Stool Antigen Tests Product
Table 180. nal von minden GmbH Recent Developments/Updates
Table 181. DIALAB GmbH Company Information
Table 182. DIALAB GmbH Description and Business Overview
Table 183. DIALAB GmbH H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 184. DIALAB GmbH H. pylori Stool Antigen Tests Product
Table 185. DIALAB GmbH Recent Developments/Updates
Table 186. Biopanda Reagents Ltd. Company Information
Table 187. Biopanda Reagents Ltd. Description and Business Overview
Table 188. Biopanda Reagents Ltd. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 189. Biopanda Reagents Ltd. H. pylori Stool Antigen Tests Product
Table 190. Biopanda Reagents Ltd. Recent Developments/Updates
Table 191. Apacor Limited Company Information
Table 192. Apacor Limited Description and Business Overview
Table 193. Apacor Limited H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 194. Apacor Limited H. pylori Stool Antigen Tests Product
Table 195. Apacor Limited Recent Developments/Updates
Table 196. Panion & BF Biotech, Inc. Company Information
Table 197. Panion & BF Biotech, Inc. Description and Business Overview
Table 198. Panion & BF Biotech, Inc. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 199. Panion & BF Biotech, Inc. H. pylori Stool Antigen Tests Product
Table 200. Panion & BF Biotech, Inc. Recent Developments/Updates
Table 201. STRONG BIOTECH CORPORATION Company Information
Table 202. STRONG BIOTECH CORPORATION Description and Business Overview
Table 203. STRONG BIOTECH CORPORATION H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 204. STRONG BIOTECH CORPORATION H. pylori Stool Antigen Tests Product
Table 205. STRONG BIOTECH CORPORATION Recent Developments/Updates
Table 206. Beijing Lepu Diagnostics Technology Co., Ltd. Company Information
Table 207. Beijing Lepu Diagnostics Technology Co., Ltd. Description and Business Overview
Table 208. Beijing Lepu Diagnostics Technology Co., Ltd. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 209. Beijing Lepu Diagnostics Technology Co., Ltd. H. pylori Stool Antigen Tests Product
Table 210. Beijing Lepu Diagnostics Technology Co., Ltd. Recent Developments/Updates
Table 211. Cofoe Medical Technology Co., Ltd. Company Information
Table 212. Cofoe Medical Technology Co., Ltd. Description and Business Overview
Table 213. Cofoe Medical Technology Co., Ltd. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 214. Cofoe Medical Technology Co., Ltd. H. pylori Stool Antigen Tests Product
Table 215. Cofoe Medical Technology Co., Ltd. Recent Developments/Updates
Table 216. Key Raw Materials Lists
Table 217. Raw Materials Key Suppliers Lists
Table 218. H. pylori Stool Antigen Tests Distributors List
Table 219. H. pylori Stool Antigen Tests Customers List
Table 220. H. pylori Stool Antigen Tests Market Trends
Table 221. H. pylori Stool Antigen Tests Market Drivers
Table 222. H. pylori Stool Antigen Tests Market Challenges
Table 223. H. pylori Stool Antigen Tests Market Restraints
Table 224. Research Programs/Design for This Report
Table 225. Key Data Information from Secondary Sources
Table 226. Key Data Information from Primary Sources
Table 227. Authors List of This Report
List of Figures
Figure 1. Product Picture of H. pylori Stool Antigen Tests
Figure 2. Global H. pylori Stool Antigen Tests Market Value by Type (US$ Million), 2021–2032
Figure 3. Global H. pylori Stool Antigen Tests Market Share by Type: 2025 & 2032
Figure 4. Lateral Flow Immunochromatography Product Picture
Figure 5. Fluorescence Immunoassay Product Picture
Figure 6. Enzyme Immunoassay Product Picture
Figure 7. Chemiluminescence Immunoassay Product Picture
Figure 8. Latex Turbidimetric Immunoassay Product Picture
Figure 9. Other Product Picture
Figure 10. Global H. pylori Stool Antigen Tests Market Value by Operating Format (US$ Million), 2021–2032
Figure 11. Global H. pylori Stool Antigen Tests Market Share by Operating Format: 2025 vs 2032
Figure 12. Visual Cassette Product Picture
Figure 13. Reader Assisted Cassette Product Picture
Figure 14. Microplate Kit Product Picture
Figure 15. Automated Analyzer Reagent Product Picture
Figure 16. Other Product Picture
Figure 17. Global H. pylori Stool Antigen Tests Market Value by Application (US$ Million), 2021–2032
Figure 18. Global H. pylori Stool Antigen Tests Market Share by Application: 2025 & 2032
Figure 19. Home Self-Testing
Figure 20. Primary Care Clinic Testing
Figure 21. Gastroenterology Clinic Testing
Figure 22. Hospital Point-of-Care Testing
Figure 23. Hospital Central Laboratory Testing
Figure 24. Independent Reference Laboratory Testing
Figure 25. Other
Figure 26. Global H. pylori Stool Antigen Tests Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 27. Global H. pylori Stool Antigen Tests Market Size (US$ Million), 2021–2032
Figure 28. Global H. pylori Stool Antigen Tests Sales (Units), 2021–2032
Figure 29. Global H. pylori Stool Antigen Tests Average Price (US$/Unit), 2021–2032
Figure 30. H. pylori Stool Antigen Tests Report Years Considered
Figure 31. H. pylori Stool Antigen Tests Sales Share by Manufacturers in 2025
Figure 32. Global H. pylori Stool Antigen Tests Revenue Share by Manufacturers in 2025
Figure 33. Top 5 and Top 10 Global H. pylori Stool Antigen Tests Players: Market Share by Revenue in H. pylori Stool Antigen Tests in 2025
Figure 34. H. pylori Stool Antigen Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 35. Global H. pylori Stool Antigen Tests Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 36. North America H. pylori Stool Antigen Tests Sales Market Share by Country (2021–2032)
Figure 37. North America H. pylori Stool Antigen Tests Revenue Market Share by Country (2021–2032)
Figure 38. United States H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Canada H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Europe H. pylori Stool Antigen Tests Sales Market Share by Country (2021–2032)
Figure 41. Europe H. pylori Stool Antigen Tests Revenue Market Share by Country (2021–2032)
Figure 42. Germany H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. France H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. U.K. H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Italy H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Russia H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Asia Pacific H. pylori Stool Antigen Tests Sales Market Share by Region (2021–2032)
Figure 48. Asia Pacific H. pylori Stool Antigen Tests Revenue Market Share by Region (2021–2032)
Figure 49. China H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Japan H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. South Korea H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. India H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Australia H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. China Taiwan H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Southeast Asia H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Latin America H. pylori Stool Antigen Tests Sales Market Share by Country (2021–2032)
Figure 57. Latin America H. pylori Stool Antigen Tests Revenue Market Share by Country (2021–2032)
Figure 58. Mexico H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Brazil H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. Argentina H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Colombia H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. Middle East and Africa H. pylori Stool Antigen Tests Sales Market Share by Country (2021–2032)
Figure 63. Middle East and Africa H. pylori Stool Antigen Tests Revenue Market Share by Country (2021–2032)
Figure 64. Turkey H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 65. Saudi Arabia H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 66. UAE H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 67. Global Sales Market Share of H. pylori Stool Antigen Tests by Type (2021–2032)
Figure 68. Global Revenue Market Share of H. pylori Stool Antigen Tests by Type (2021–2032)
Figure 69. Global H. pylori Stool Antigen Tests Price (US$/Unit) by Type (2021–2032)
Figure 70. Global Sales Market Share of H. pylori Stool Antigen Tests by Application (2021–2032)
Figure 71. Global Revenue Market Share of H. pylori Stool Antigen Tests by Application (2021–2032)
Figure 72. Global H. pylori Stool Antigen Tests Price (US$/Unit) by Application (2021–2032)
Figure 73. H. pylori Stool Antigen Tests Value Chain
Figure 74. Channels of Distribution (Direct Vs Distribution)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
Table 1. Global H. pylori Stool Antigen Tests Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global H. pylori Stool Antigen Tests Market Value by Operating Format (US$ Million), 2025 vs 2032
Table 3. Global H. pylori Stool Antigen Tests Market Value by Application (US$ Million), 2025 vs 2032
Table 4. Global H. pylori Stool Antigen Tests Market Competitive Situation by Manufacturers in 2025
Table 5. Global H. pylori Stool Antigen Tests Sales (Units) of Key Manufacturers (2021–2026)
Table 6. Global H. pylori Stool Antigen Tests Sales Market Share by Manufacturers (2021–2026)
Table 7. Global H. pylori Stool Antigen Tests Revenue (US$ Million) by Manufacturers (2021–2026)
Table 8. Global H. pylori Stool Antigen Tests Revenue Share by Manufacturers (2021–2026)
Table 9. Global Market H. pylori Stool Antigen Tests Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 10. Global Key Players of H. pylori Stool Antigen Tests, Industry Ranking, 2023 vs 2024 vs 2025
Table 11. Global Key Manufacturers of H. pylori Stool Antigen Tests, Manufacturing Sites and Headquarters
Table 12. Global Key Manufacturers of H. pylori Stool Antigen Tests, Product Types and Applications
Table 13. Global Key Manufacturers of H. pylori Stool Antigen Tests, Date of Entry into the Industry
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global H. pylori Stool Antigen Tests Companies by Tier (Tier 1, Tier 2, Tier 3), based on H. pylori Stool Antigen Tests Revenue, 2025
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Global H. pylori Stool Antigen Tests Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 18. Global H. pylori Stool Antigen Tests Sales by Region (Units), 2021–2026
Table 19. Global H. pylori Stool Antigen Tests Sales Market Share by Region (2021–2026)
Table 20. Global H. pylori Stool Antigen Tests Sales by Region (Units), 2027–2032
Table 21. Global H. pylori Stool Antigen Tests Sales Market Share by Region (2027–2032)
Table 22. Global H. pylori Stool Antigen Tests Revenue by Region (US$ Million), 2021–2026
Table 23. Global H. pylori Stool Antigen Tests Revenue Market Share by Region (2021–2026)
Table 24. Global H. pylori Stool Antigen Tests Revenue by Region (US$ Million), 2027–2032
Table 25. Global H. pylori Stool Antigen Tests Revenue Market Share by Region (2027–2032)
Table 26. North America H. pylori Stool Antigen Tests Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 27. North America H. pylori Stool Antigen Tests Sales by Country (Units), 2021–2026
Table 28. North America H. pylori Stool Antigen Tests Sales by Country (Units), 2027–2032
Table 29. North America H. pylori Stool Antigen Tests Revenue by Country (US$ Million), 2021–2026
Table 30. North America H. pylori Stool Antigen Tests Revenue by Country (US$ Million), 2027–2032
Table 31. Europe H. pylori Stool Antigen Tests Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 32. Europe H. pylori Stool Antigen Tests Sales by Country (Units), 2021–2026
Table 33. Europe H. pylori Stool Antigen Tests Sales by Country (Units), 2027–2032
Table 34. Europe H. pylori Stool Antigen Tests Revenue by Country (US$ Million), 2021–2026
Table 35. Europe H. pylori Stool Antigen Tests Revenue by Country (US$ Million), 2027–2032
Table 36. Asia Pacific H. pylori Stool Antigen Tests Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 37. Asia Pacific H. pylori Stool Antigen Tests Sales by Region (Units), 2021–2026
Table 38. Asia Pacific H. pylori Stool Antigen Tests Sales by Region (Units), 2027–2032
Table 39. Asia Pacific H. pylori Stool Antigen Tests Revenue by Region (US$ Million), 2021–2026
Table 40. Asia Pacific H. pylori Stool Antigen Tests Revenue by Region (US$ Million), 2027–2032
Table 41. Latin America H. pylori Stool Antigen Tests Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 42. Latin America H. pylori Stool Antigen Tests Sales by Country (Units), 2021–2026
Table 43. Latin America H. pylori Stool Antigen Tests Sales by Country (Units), 2027–2032
Table 44. Latin America H. pylori Stool Antigen Tests Revenue by Country (US$ Million), 2021–2026
Table 45. Latin America H. pylori Stool Antigen Tests Revenue by Country (US$ Million), 2027–2032
Table 46. Middle East and Africa H. pylori Stool Antigen Tests Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 47. Middle East and Africa H. pylori Stool Antigen Tests Sales by Country (Units), 2021–2026
Table 48. Middle East and Africa H. pylori Stool Antigen Tests Sales by Country (Units), 2027–2032
Table 49. Middle East and Africa H. pylori Stool Antigen Tests Revenue by Country (US$ Million), 2021–2026
Table 50. Middle East and Africa H. pylori Stool Antigen Tests Revenue by Country (US$ Million), 2027–2032
Table 51. Global H. pylori Stool Antigen Tests Sales (Units) by Type (2021–2026)
Table 52. Global H. pylori Stool Antigen Tests Sales (Units) by Type (2027–2032)
Table 53. Global H. pylori Stool Antigen Tests Sales Market Share by Type (2021–2026)
Table 54. Global H. pylori Stool Antigen Tests Sales Market Share by Type (2027–2032)
Table 55. Global H. pylori Stool Antigen Tests Revenue (US$ Million) by Type (2021–2026)
Table 56. Global H. pylori Stool Antigen Tests Revenue (US$ Million) by Type (2027–2032)
Table 57. Global H. pylori Stool Antigen Tests Revenue Market Share by Type (2021–2026)
Table 58. Global H. pylori Stool Antigen Tests Revenue Market Share by Type (2027–2032)
Table 59. Global H. pylori Stool Antigen Tests Price (US$/Unit) by Type (2021–2026)
Table 60. Global H. pylori Stool Antigen Tests Price (US$/Unit) by Type (2027–2032)
Table 61. Global H. pylori Stool Antigen Tests Sales (Units) by Application (2021–2026)
Table 62. Global H. pylori Stool Antigen Tests Sales (Units) by Application (2027–2032)
Table 63. Global H. pylori Stool Antigen Tests Sales Market Share by Application (2021–2026)
Table 64. Global H. pylori Stool Antigen Tests Sales Market Share by Application (2027–2032)
Table 65. Global H. pylori Stool Antigen Tests Revenue (US$ Million) by Application (2021–2026)
Table 66. Global H. pylori Stool Antigen Tests Revenue (US$ Million) by Application (2027–2032)
Table 67. Global H. pylori Stool Antigen Tests Revenue Market Share by Application (2021–2026)
Table 68. Global H. pylori Stool Antigen Tests Revenue Market Share by Application (2027–2032)
Table 69. Global H. pylori Stool Antigen Tests Price (US$/Unit) by Application (2021–2026)
Table 70. Global H. pylori Stool Antigen Tests Price (US$/Unit) by Application (2027–2032)
Table 71. Abbott Laboratories Company Information
Table 72. Abbott Laboratories Description and Business Overview
Table 73. Abbott Laboratories H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 74. Abbott Laboratories H. pylori Stool Antigen Tests Product
Table 75. Abbott Laboratories Recent Developments/Updates
Table 76. SD Biosensor, Inc. Company Information
Table 77. SD Biosensor, Inc. Description and Business Overview
Table 78. SD Biosensor, Inc. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 79. SD Biosensor, Inc. H. pylori Stool Antigen Tests Product
Table 80. SD Biosensor, Inc. Recent Developments/Updates
Table 81. SSI Diagnostica A/S Company Information
Table 82. SSI Diagnostica A/S Description and Business Overview
Table 83. SSI Diagnostica A/S H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 84. SSI Diagnostica A/S H. pylori Stool Antigen Tests Product
Table 85. SSI Diagnostica A/S Recent Developments/Updates
Table 86. ACON Laboratories, Inc. Company Information
Table 87. ACON Laboratories, Inc. Description and Business Overview
Table 88. ACON Laboratories, Inc. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 89. ACON Laboratories, Inc. H. pylori Stool Antigen Tests Product
Table 90. ACON Laboratories, Inc. Recent Developments/Updates
Table 91. Guangzhou Wondfo Biotech Co., Ltd. Company Information
Table 92. Guangzhou Wondfo Biotech Co., Ltd. Description and Business Overview
Table 93. Guangzhou Wondfo Biotech Co., Ltd. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 94. Guangzhou Wondfo Biotech Co., Ltd. H. pylori Stool Antigen Tests Product
Table 95. Guangzhou Wondfo Biotech Co., Ltd. Recent Developments/Updates
Table 96. Zhejiang Orient Gene Biotech Co., Ltd. Company Information
Table 97. Zhejiang Orient Gene Biotech Co., Ltd. Description and Business Overview
Table 98. Zhejiang Orient Gene Biotech Co., Ltd. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 99. Zhejiang Orient Gene Biotech Co., Ltd. H. pylori Stool Antigen Tests Product
Table 100. Zhejiang Orient Gene Biotech Co., Ltd. Recent Developments/Updates
Table 101. HANGZHOU ALLTEST BIOTECH CO., LTD. Company Information
Table 102. HANGZHOU ALLTEST BIOTECH CO., LTD. Description and Business Overview
Table 103. HANGZHOU ALLTEST BIOTECH CO., LTD. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 104. HANGZHOU ALLTEST BIOTECH CO., LTD. H. pylori Stool Antigen Tests Product
Table 105. HANGZHOU ALLTEST BIOTECH CO., LTD. Recent Developments/Updates
Table 106. R-Biopharm AG Company Information
Table 107. R-Biopharm AG Description and Business Overview
Table 108. R-Biopharm AG H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 109. R-Biopharm AG H. pylori Stool Antigen Tests Product
Table 110. R-Biopharm AG Recent Developments/Updates
Table 111. Denka Company Limited Company Information
Table 112. Denka Company Limited Description and Business Overview
Table 113. Denka Company Limited H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 114. Denka Company Limited H. pylori Stool Antigen Tests Product
Table 115. Denka Company Limited Recent Developments/Updates
Table 116. Autobio Diagnostics Co., Ltd. Company Information
Table 117. Autobio Diagnostics Co., Ltd. Description and Business Overview
Table 118. Autobio Diagnostics Co., Ltd. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 119. Autobio Diagnostics Co., Ltd. H. pylori Stool Antigen Tests Product
Table 120. Autobio Diagnostics Co., Ltd. Recent Developments/Updates
Table 121. Getein Biotech, Inc. Company Information
Table 122. Getein Biotech, Inc. Description and Business Overview
Table 123. Getein Biotech, Inc. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 124. Getein Biotech, Inc. H. pylori Stool Antigen Tests Product
Table 125. Getein Biotech, Inc. Recent Developments/Updates
Table 126. Sentinel Diagnostics Company Information
Table 127. Sentinel Diagnostics Description and Business Overview
Table 128. Sentinel Diagnostics H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 129. Sentinel Diagnostics H. pylori Stool Antigen Tests Product
Table 130. Sentinel Diagnostics Recent Developments/Updates
Table 131. Boditech Med Inc. Company Information
Table 132. Boditech Med Inc. Description and Business Overview
Table 133. Boditech Med Inc. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 134. Boditech Med Inc. H. pylori Stool Antigen Tests Product
Table 135. Boditech Med Inc. Recent Developments/Updates
Table 136. Certest Biotec, S.L. Company Information
Table 137. Certest Biotec, S.L. Description and Business Overview
Table 138. Certest Biotec, S.L. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 139. Certest Biotec, S.L. H. pylori Stool Antigen Tests Product
Table 140. Certest Biotec, S.L. Recent Developments/Updates
Table 141. MIZUHO MEDY Co., Ltd. Company Information
Table 142. MIZUHO MEDY Co., Ltd. Description and Business Overview
Table 143. MIZUHO MEDY Co., Ltd. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 144. MIZUHO MEDY Co., Ltd. H. pylori Stool Antigen Tests Product
Table 145. MIZUHO MEDY Co., Ltd. Recent Developments/Updates
Table 146. Wakamoto Pharmaceutical Co., Ltd. Company Information
Table 147. Wakamoto Pharmaceutical Co., Ltd. Description and Business Overview
Table 148. Wakamoto Pharmaceutical Co., Ltd. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 149. Wakamoto Pharmaceutical Co., Ltd. H. pylori Stool Antigen Tests Product
Table 150. Wakamoto Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 151. Humasis Co., Ltd. Company Information
Table 152. Humasis Co., Ltd. Description and Business Overview
Table 153. Humasis Co., Ltd. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 154. Humasis Co., Ltd. H. pylori Stool Antigen Tests Product
Table 155. Humasis Co., Ltd. Recent Developments/Updates
Table 156. Innovita Biological Technology Co., Ltd. Company Information
Table 157. Innovita Biological Technology Co., Ltd. Description and Business Overview
Table 158. Innovita Biological Technology Co., Ltd. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 159. Innovita Biological Technology Co., Ltd. H. pylori Stool Antigen Tests Product
Table 160. Innovita Biological Technology Co., Ltd. Recent Developments/Updates
Table 161. Assure Tech Hangzhou Co., Ltd. Company Information
Table 162. Assure Tech Hangzhou Co., Ltd. Description and Business Overview
Table 163. Assure Tech Hangzhou Co., Ltd. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 164. Assure Tech Hangzhou Co., Ltd. H. pylori Stool Antigen Tests Product
Table 165. Assure Tech Hangzhou Co., Ltd. Recent Developments/Updates
Table 166. Trinity Biotech plc Company Information
Table 167. Trinity Biotech plc Description and Business Overview
Table 168. Trinity Biotech plc H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 169. Trinity Biotech plc H. pylori Stool Antigen Tests Product
Table 170. Trinity Biotech plc Recent Developments/Updates
Table 171. Savyon Diagnostics Ltd. Company Information
Table 172. Savyon Diagnostics Ltd. Description and Business Overview
Table 173. Savyon Diagnostics Ltd. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 174. Savyon Diagnostics Ltd. H. pylori Stool Antigen Tests Product
Table 175. Savyon Diagnostics Ltd. Recent Developments/Updates
Table 176. nal von minden GmbH Company Information
Table 177. nal von minden GmbH Description and Business Overview
Table 178. nal von minden GmbH H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 179. nal von minden GmbH H. pylori Stool Antigen Tests Product
Table 180. nal von minden GmbH Recent Developments/Updates
Table 181. DIALAB GmbH Company Information
Table 182. DIALAB GmbH Description and Business Overview
Table 183. DIALAB GmbH H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 184. DIALAB GmbH H. pylori Stool Antigen Tests Product
Table 185. DIALAB GmbH Recent Developments/Updates
Table 186. Biopanda Reagents Ltd. Company Information
Table 187. Biopanda Reagents Ltd. Description and Business Overview
Table 188. Biopanda Reagents Ltd. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 189. Biopanda Reagents Ltd. H. pylori Stool Antigen Tests Product
Table 190. Biopanda Reagents Ltd. Recent Developments/Updates
Table 191. Apacor Limited Company Information
Table 192. Apacor Limited Description and Business Overview
Table 193. Apacor Limited H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 194. Apacor Limited H. pylori Stool Antigen Tests Product
Table 195. Apacor Limited Recent Developments/Updates
Table 196. Panion & BF Biotech, Inc. Company Information
Table 197. Panion & BF Biotech, Inc. Description and Business Overview
Table 198. Panion & BF Biotech, Inc. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 199. Panion & BF Biotech, Inc. H. pylori Stool Antigen Tests Product
Table 200. Panion & BF Biotech, Inc. Recent Developments/Updates
Table 201. STRONG BIOTECH CORPORATION Company Information
Table 202. STRONG BIOTECH CORPORATION Description and Business Overview
Table 203. STRONG BIOTECH CORPORATION H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 204. STRONG BIOTECH CORPORATION H. pylori Stool Antigen Tests Product
Table 205. STRONG BIOTECH CORPORATION Recent Developments/Updates
Table 206. Beijing Lepu Diagnostics Technology Co., Ltd. Company Information
Table 207. Beijing Lepu Diagnostics Technology Co., Ltd. Description and Business Overview
Table 208. Beijing Lepu Diagnostics Technology Co., Ltd. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 209. Beijing Lepu Diagnostics Technology Co., Ltd. H. pylori Stool Antigen Tests Product
Table 210. Beijing Lepu Diagnostics Technology Co., Ltd. Recent Developments/Updates
Table 211. Cofoe Medical Technology Co., Ltd. Company Information
Table 212. Cofoe Medical Technology Co., Ltd. Description and Business Overview
Table 213. Cofoe Medical Technology Co., Ltd. H. pylori Stool Antigen Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 214. Cofoe Medical Technology Co., Ltd. H. pylori Stool Antigen Tests Product
Table 215. Cofoe Medical Technology Co., Ltd. Recent Developments/Updates
Table 216. Key Raw Materials Lists
Table 217. Raw Materials Key Suppliers Lists
Table 218. H. pylori Stool Antigen Tests Distributors List
Table 219. H. pylori Stool Antigen Tests Customers List
Table 220. H. pylori Stool Antigen Tests Market Trends
Table 221. H. pylori Stool Antigen Tests Market Drivers
Table 222. H. pylori Stool Antigen Tests Market Challenges
Table 223. H. pylori Stool Antigen Tests Market Restraints
Table 224. Research Programs/Design for This Report
Table 225. Key Data Information from Secondary Sources
Table 226. Key Data Information from Primary Sources
Table 227. Authors List of This Report
List of Figures
Figure 1. Product Picture of H. pylori Stool Antigen Tests
Figure 2. Global H. pylori Stool Antigen Tests Market Value by Type (US$ Million), 2021–2032
Figure 3. Global H. pylori Stool Antigen Tests Market Share by Type: 2025 & 2032
Figure 4. Lateral Flow Immunochromatography Product Picture
Figure 5. Fluorescence Immunoassay Product Picture
Figure 6. Enzyme Immunoassay Product Picture
Figure 7. Chemiluminescence Immunoassay Product Picture
Figure 8. Latex Turbidimetric Immunoassay Product Picture
Figure 9. Other Product Picture
Figure 10. Global H. pylori Stool Antigen Tests Market Value by Operating Format (US$ Million), 2021–2032
Figure 11. Global H. pylori Stool Antigen Tests Market Share by Operating Format: 2025 vs 2032
Figure 12. Visual Cassette Product Picture
Figure 13. Reader Assisted Cassette Product Picture
Figure 14. Microplate Kit Product Picture
Figure 15. Automated Analyzer Reagent Product Picture
Figure 16. Other Product Picture
Figure 17. Global H. pylori Stool Antigen Tests Market Value by Application (US$ Million), 2021–2032
Figure 18. Global H. pylori Stool Antigen Tests Market Share by Application: 2025 & 2032
Figure 19. Home Self-Testing
Figure 20. Primary Care Clinic Testing
Figure 21. Gastroenterology Clinic Testing
Figure 22. Hospital Point-of-Care Testing
Figure 23. Hospital Central Laboratory Testing
Figure 24. Independent Reference Laboratory Testing
Figure 25. Other
Figure 26. Global H. pylori Stool Antigen Tests Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 27. Global H. pylori Stool Antigen Tests Market Size (US$ Million), 2021–2032
Figure 28. Global H. pylori Stool Antigen Tests Sales (Units), 2021–2032
Figure 29. Global H. pylori Stool Antigen Tests Average Price (US$/Unit), 2021–2032
Figure 30. H. pylori Stool Antigen Tests Report Years Considered
Figure 31. H. pylori Stool Antigen Tests Sales Share by Manufacturers in 2025
Figure 32. Global H. pylori Stool Antigen Tests Revenue Share by Manufacturers in 2025
Figure 33. Top 5 and Top 10 Global H. pylori Stool Antigen Tests Players: Market Share by Revenue in H. pylori Stool Antigen Tests in 2025
Figure 34. H. pylori Stool Antigen Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 35. Global H. pylori Stool Antigen Tests Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 36. North America H. pylori Stool Antigen Tests Sales Market Share by Country (2021–2032)
Figure 37. North America H. pylori Stool Antigen Tests Revenue Market Share by Country (2021–2032)
Figure 38. United States H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Canada H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Europe H. pylori Stool Antigen Tests Sales Market Share by Country (2021–2032)
Figure 41. Europe H. pylori Stool Antigen Tests Revenue Market Share by Country (2021–2032)
Figure 42. Germany H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. France H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. U.K. H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Italy H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Russia H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Asia Pacific H. pylori Stool Antigen Tests Sales Market Share by Region (2021–2032)
Figure 48. Asia Pacific H. pylori Stool Antigen Tests Revenue Market Share by Region (2021–2032)
Figure 49. China H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Japan H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. South Korea H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. India H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Australia H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. China Taiwan H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Southeast Asia H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Latin America H. pylori Stool Antigen Tests Sales Market Share by Country (2021–2032)
Figure 57. Latin America H. pylori Stool Antigen Tests Revenue Market Share by Country (2021–2032)
Figure 58. Mexico H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Brazil H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. Argentina H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Colombia H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. Middle East and Africa H. pylori Stool Antigen Tests Sales Market Share by Country (2021–2032)
Figure 63. Middle East and Africa H. pylori Stool Antigen Tests Revenue Market Share by Country (2021–2032)
Figure 64. Turkey H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 65. Saudi Arabia H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 66. UAE H. pylori Stool Antigen Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 67. Global Sales Market Share of H. pylori Stool Antigen Tests by Type (2021–2032)
Figure 68. Global Revenue Market Share of H. pylori Stool Antigen Tests by Type (2021–2032)
Figure 69. Global H. pylori Stool Antigen Tests Price (US$/Unit) by Type (2021–2032)
Figure 70. Global Sales Market Share of H. pylori Stool Antigen Tests by Application (2021–2032)
Figure 71. Global Revenue Market Share of H. pylori Stool Antigen Tests by Application (2021–2032)
Figure 72. Global H. pylori Stool Antigen Tests Price (US$/Unit) by Application (2021–2032)
Figure 73. H. pylori Stool Antigen Tests Value Chain
Figure 74. Channels of Distribution (Direct Vs Distribution)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Physical Graphing Calculators Market Research Report 2026
Nov 14, 26
Global Graphics Calculators Market Research Report 2026
Nov 14, 26
Global Internet and Wi-fi Connected Smart Dishwashers Market Research Report 2026
Nov 14, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232